Comprehensive Physiology Wiley Online Library
For Librarians For Authors Editors About

Cutaneous Vasodilator and Vasoconstrictor Mechanisms in Temperature Regulation

John M. Johnson, Christopher T. Minson, Dean L. Kellogg

10.1002/cphy.c130015

Source: Volume 4, Issue 1, January 2014

Published online: January 2014

Full Article on Wiley Online Library



Abstract

In this review, we focus on significant developments in our understanding of the mechanisms that control the cutaneous vasculature in humans, with emphasis on the literature of the last half‐century. To provide a background for subsequent sections, we review methods of measurement and techniques of importance in elucidating control mechanisms for studying skin blood flow. In addition, the anatomy of the skin relevant to its thermoregulatory function is outlined. The mechanisms by which sympathetic nerves mediate cutaneous active vasodilation during whole body heating and cutaneous vasoconstriction during whole body cooling are reviewed, including discussions of mechanisms involving cotransmission, NO, and other effectors. Current concepts for the mechanisms that effect local cutaneous vascular responses to local skin warming and cooling are examined, including the roles of temperature sensitive afferent neurons as well as NO and other mediators. Factors that can modulate control mechanisms of the cutaneous vasculature, such as gender, aging, and clinical conditions, are discussed, as are nonthermoregulatory reflex modifiers of thermoregulatory cutaneous vascular responses. © 2014 American Physiological Society. Compr Physiol 4:33‐89, 2014.

Comprehensive Physiology offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images


Figure 1. Figure 1. Summary of the changes in cardiac output and its distribution during whole body heat stress in resting subjects. Note that the blood flow to the major visceral circulations is reduced at a time cardiac output is significantly increased, indicating the average increase in blood flow to skin equaled or exceeded 7.8 L·min−1. Adapted, with permission, from Rowell (331).
Figure 2. Figure 2. Edholm et al. (92) demonstrated that thermoregulatory reflex vasodilation was dependent on neural activation by anaesthetizing the cutaneous nerves after activating the heat stress response by whole body heating. Forearm blood flow was measured in each forearm under normothermic conditions. Heat stress was then induced and when forearm blood flow had increased and stabilized, the skin of one forearm was anesthetized with lidocaine injections and forearm blood flow measurements continued. The upper three figures show the effect of cutaneous nerve block performed during whole body heating after forearm blood flow has increased. Control experiments were performed with saline in lieu of lidocaine. The results of this substitution are shown in the lower three figures.
Figure 3. Figure 3. Response in forearm skin blood flow to local and combined local and whole body heating, as functions of internal temperature (Tes). The filled symbols are from the arm initially warmed to 42°C. The open symbols are from the arm maintained at 34°C throughout. While the arms were at those temperatures, the subject underwent whole body heat stress. Note that the blood flow in the two arms reached the same level, indicating that either local warming to 42°C or the reflex response to whole body heat stress can maximally vasodilate the skin. Adapted, with permission, from Taylor et al. (399).
Figure 4. Figure 4. Responses in forearm blood flow and esophageal temperature to small cycles in whole body skin temperature. The data in the upper panel are from a forearm that was maintained at a neutral temperature throughout and the data in the second panel are from a forearm that had the surface temperature cycle with skin temperature. The vasoconstrictor response to the approximately 2°C reductions in skin temperature was sufficient to limit heat loss and cause internal temperature to increase. In this range, the response was almost entirely due to reflex vasoconstriction, as the variation in local temperature did not notably affect the response. Adapted, with permission, from Savage and Brengelmann (342).
Figure 5. Figure 5. Responses in cutaneous vascular conductance (CVC) to changes in internal temperature caused by mild exercise. Whole body skin temperature (Tsk) and local temperature at the site of blood flow measurement (Tloc) were independently controlled in a series of four experiments in which one or the other was cooled. The open symbols are data from control skin sites and the filled symbols are from skin sites pretreated with the antiadrenergic compound bretylium. Note that a cool Tsk shifts the relationship to a higher threshold and that shift is unaffected by vasoconstrictor nerve blockade (panels A vs. C). Note also that local cooling does not have any obvious effect on the threshold, but does reduce the sensitivity of the CVC‐esophageal temperature relationship and that reduction in sensitivity is reversed by vasoconstrictor nerve blockade. Adapted, with permission, from Pérgola et al. (308).
Figure 6. Figure 6. (A) Example of the effects of NOS blockade with L‐NAME on responses to cold stress (CS1 and CS2), whole body heating, and sodium nitroprusside infusion (SNP). Cutaneous vascular responses to cold stress were unaltered by L‐NAME treatment; however, the increase in cutaneous vascular conductance during whole body heating was attenuated. Sweat rate response was unaltered by L‐NAME. Adapted, with permission, from Kellogg et al. (216). (B) Example of cutaneous vascular conductance responses to intra‐arterial infusion of Ach, L‐NMMA, and nitroprusside (NTP) during whole body heating. Cutaneous vascular responses to whole body heating were attenuated by L‐NMMA infusion indicating that NO participates in cutaneous active vasodilation. Adapted, with permission, from Shastry et al. (351).
Figure 7. Figure 7. Influence of antagonism of nNOS via intradermal 7‐NI on the vasodilator response to whole body heating and (top panel) and to direct skin warming (lower panel). Note that the reflex effects were significantly reduced, whereas the response to direct local warming was unaffected. Adapted, with permission, from Kellogg et al. (231).
Figure 8. Figure 8. Effect of intradermal botulinum toxin on cutaneous active vasodilation, vasoconstriction, and sweating from one subject. The top panel shows sweating responses at an untreated site and at a botulinum toxin‐treated site. The lower panel shows cutaneous vascular conductance responses recorded simultaneously from the same sites as sweating. Periods of whole‐body cold stress (min 10‐13), whole‐body heating (min 26‐63), and local warming of the LDF sites (min 72‐112) are indicated. During cold stress, there was a fall in CVC at both sites, demonstrating cutaneous vasoconstriction. During heat stress, the untreated site showed a typical cutaneous vasodilation. No vasodilation occurred at the site pretreated with botulinum toxin. Sweating occurred at the untreated site, but not at the botulinum toxin‐treated site. These results indicate that cholinergic nerves mediate cutaneous active vasodilation. Given the results from atropinization above, this result demonstrates that mediation is via release of a cotransmitter. Adapted, with permission, from Kellogg et al. (227).
Figure 9. Figure 9. Evidence that VIP may affect a portion of cutaneous active vasodilation. Forearm sites were treated with atropine, the antagonist VIP(10‐28), both antagonists, or Ringer solution only. (A) The magnitude of the change in cutaneous vascular conductance during the last 2 min of whole body heating was not statistically different among treatment sites (‡p = 0.08); however, one subject displayed a dramatic, unexplained vasodilatation during the last 7 min of heat stress at the VIP(10‐28)‐treatment site only. (B) With this subject removed, VIP(10‐28) reduced the vasodilator response significantly Atropine did not significantly affect the magnitude of the vasodilation (15).
Figure 10. Figure 10. The effect of NK1 receptor desensitization on the plateau in skin blood flow achieved during whole‐body heating. The vasodilator response to whole body heating was significantly reduced in sites where substance P pretreatment was given when compared to untreated control sites. NOS inhibited sites that received L‐NAME only were attenuated compared to both untreated control sites and substance P desensitized sites. Responses at sites pretreated with substance P and L‐NAME were significantly reduced compared to all other sites. Adapted, with permission, from Wong and Minson (448).
Figure 11. Figure 11. Effect of TRPV1 channel antagonism with capsazepine, NOS blockade with L‐NAME, and combined TRPV1 and NOS during whole body heating as a function of increasing oral temperature (Tor). Cutaneous vascular conductance increases at sites treated capsazepine, L‐NAME, and combined capsazepine/L‐NAME sites were attenuated compared to untreated control sites. L‐NAME treatment whether with or without capsazepine produced similar degrees of attenuation. These results indicate that TRPV‐1 channels affect a portion of cutaneous active vasodilation and involve NO generation by NOS. Adapted, with permission, from Wong and Fieger (447).
Figure 12. Figure 12. An example of the effect of cyclooxygenase antagonism by ketorolac (KETO) with and without NOS blockade by L‐NAME on cutaneous vascular conductance responses to whole body heating. In normothermia, cutaneous vascular conductance did not differ among sites. In response to whole body heating cutaneous vascular conductance at all treated sites was significantly attenuated when compared to untreated control sites. Cutaneous vascular conductance at the combined KETO and L‐NAME site was significantly attenuated when compared to sites treated with KETO or L‐NAME alone. These results are consistent with involvement of the cyclooxygenase pathway in cutaneous active vasodilation through NO‐independent mechanisms. Adapted, with permission, from McCord et al. (279).
Figure 13. Figure 13. Summary of the Mechanisms Contributing to Active Vasodilation. In the left panel, a typical tracing of the skin blood flow response to whole body heating is presented, displaying baseline skin blood flow (expressed as percent of maximal cutaneous vascular conductance), the initial rise in skin blood flow representing release of tonic vasoconstrictor tone, and the subsequent rise in skin blood flow attributed to active vasodilation by sympathetic cholinergic nerves. In the right panel, a schematic of the current theory of cutaneous active vasodilation is presented. Acetylcholine (Ach) is released and contributes to the early rise in cutaneous active vasodilation and causes a simultaneous activation of sweat glands. The purported cotransmitters with Ach include vasoactive intestinal peptide (VIP) and/or pituitary adenylate cyclase‐activating peptide (PACAP). These will then bind to the pituitary adenylate cyclase‐activating peptide 1 receptor (PAC1) or the vasoactive intestinal peptide receptor 1 or 2 (VPAC1 or VPAC2). Evidence suggests a potential role for histamine acting via histamine‐1 receptors (H1), as well as activation of transient receptor potential vanilloid receptor 1 (TRPV‐1). These two pathways [and Ach via muscarinic receptor‐ 3 (M3)] appear to work through nitric oxide (NO) to contribute up to 40% to 50% of active vasodilation. Recent evidence demonstrates it is the neural NO synthase (nNOS) isoform. In addition, prostacyclin (PGI2) contributes to active vasodilation via the cyclooxygenase pathway (COX). A role for substance P via the neurokinin‐1 receptor (NK1) has also been described, although the specific mechanisms of this pathway have not been determined.
Figure 14. Figure 14. (A) Vasoconstrictor responses to reductions in whole body skin temperature from skin sites treated with the Y1 NPY receptor antagonist BIBP‐3226 (upper curve) or with Ringer's solution (lower curve), both by microdialysis. The NPY receptor antagonist inhibited the vasoconstrictor response. (B) Response to reduced whole body skin temperature at skin sites treated with Ringer's (control), Yohimbine and Propranolol (adrenergic antagonism) and Yohimbine, Propranolol plus BIBP‐3226 for adrenergic and NPY Y1 receptor blockade. Note that either adrenergic receptor blockade or NPY receptor blockade reduced the vasoconstrictor response to cooling, and that the combination eliminated the response, indicating a cotransmitter role for NPY in reflex cutaneous vasoconstriction. Adapted, with permission, from Stephens et al. (372).
Figure 15. Figure 15. Summary of the Mechanisms Contributing to Thermal Hyperemia. In the top left of the figure, a typical tracing of the skin blood flow response to rapid local heating to 42°C is presented, displaying an Initial Peak, a subsequent drop to a Nadir, and a further vasodilation to a sustained Plateau. This is often followed by an attenuation of the Plateau phase during the “die‐away” phenomenon. The middle figure displays the current theory behind the vasodilation to local heating during the Initial Peak, and the bottom figure displays the current theory behind vasodilation during the Plateau Phase. In both figures, pathways in the endothelium and the smooth muscle are presented. Roles for both sensory/nociceptive nerves releasing substance P (SP) and calcitonin gene‐related peptide (CGRP) and adrenergic nerves releasing norepinephrine (NE) and neuropeptide Y (NPY) are also shown. In both phases, vasodilation occurs through complex pathways that lead to the production of NO and smooth muscle relaxation via hyperpolarization from endothelial derived hyperpolarization factors (EDHFs). Potential sources of endothelial derived NO identified to date include the transient receptor peptide TRPV1, the adenosine receptors (A1 and A2), NK1‐receptor activation by SP, CGRP, and β2 receptor activation. Potential EDHFs include the epoxyeicosatrienoic acids (EETs), the lipoxygenase (LOX) derivatives 12‐(S)‐hydroxyeicosatetraenoic acid (12‐S‐HETE) and 11,12,15‐trihydroxyeicosatrienoic acid (11,12,15‐THETA), and H2O2.
Figure 16. Figure 16. Responses in CVC to slow local heating (panel A) and rapid local heating (panel B) from control sites and sites pretreated with bretylium (BT). Slow local heating causes an axon reflex (*). Under conditions of adrenergic blockade with BT, the axon reflex was abolished and a lower peak vasodilator response achieved. Rapid local heating caused a more pronounced axon reflex and a greater peak vasodilator response at the untreated site. Pretreatment with BT reduced (p < 0.05) but did not abolish the axon reflex to rapid heating. BT also causes an attenuated peak vasodilator response to local heating. The untreated sites showed a decline in CVC following rapid heating. This “die away” phenomenon was abolished by pretreatment with BT. †p < 0.05, CVC at these points is significantly higher at the untreated sites compared with that at the BT treated sites for that heating protocol. From Hodges et al. (157).
Figure 17. Figure 17. NOS isoforms and the responses to local skin warming. At a local skin temperature (Tloc) of 34°C, CVC values, normalized to their respective maxima, did not differ significantly among untreated, LNAA treated (eNOS antagonist), NPLA treated (nNOS antagonist) or their combination. CVC increased in response to local skin warming at all sites but that increase was significantly inhibited at the site with eNOS antagonism (228).
Figure 18. Figure 18. Representative tracing during local heating to 42°C from one subject from Brunt and Minson (41). Four microdialysis sites were infused with Ringer solution (Control), tetraethylammonium (TEA), NG‐nitro‐l‐arginine methyl ester (L‐NAME), and TEA+L‐NAME. Data are expressed as a percent of maximal CVC obtained from infusion of 56 mmol/L sodium nitroprusside. Initial Peak, Nadir, and Plateau phase responses were all reduced with TEA (to block calcium‐activated potassium channels; KCa). Combined blockade with TEA and L‐NAME nearly abolished all vasodilation during local heating, demonstrating that KCa channels have a profound role in the Initial Peak response to local heating, and account for the remaining ∼40% of vasodilation during the Plateau phase not inhibited by NO‐synthase inhibition alone (41).
Figure 19. Figure 19. (A) Effects of blockade of adrenergic receptors with yohimbine and propranolol (Y + P), the rho kinase inhibitor fasudil and their combination on the vasoconstrictor response to locally applied norepinephrine. (B) The effects of the same antagonists on the vasoconstrictor response to local skin cooling. Either antagonist reduced, but did not eliminate the response. Importantly, the combination of Y+P+ fasudil did not have an effect greater than that by fasudil alone, suggesting the adrenergic portion of the response to local skin cooling was through the rho kinase system. Adapted, with permission, from Thompson‐Torgerson et al. (407).
Figure 20. Figure 20. Effect of local treatment of skin with ascorbic acid on the vasoconstrictor response to local cooling (reduced Tloc at 0 min) and to reduced whole body skin temperature (Mean Tsk). Note that the vasoconstrictor response to local skin cooling was reduced by ascorbic acid treatment, suggesting a role for reactive oxygen species in the control response. Adapted, with permission, From Yamazaki (456).
Figure 21. Figure 21. Role of adrenergic nerves and NOS in the cutaneous vascular response to local skin cooling from 34 to 24°C. Sites were pretreated with bretylium to eliminate transmitter release from vasoconstrictor nerve terminals. NOS were inhibited at both sites, beginning at min 20, causing a vasoconstriction to develop over the next 35 min. At one site, NO and basely e CVC were restored via exogenous sodium nitroprusside (SNP; filled symbols). Local cooling was then applied to both sites between min 85 and 115. Note that in the site without exogenous SNP (open symbols), there was no vasoconstrictor response to local cooling, indicating the normal vasoconstrictor response to be dependent on a combination of NOS inhibition and adrenergic activation. At the site with NO and baseline blood flow restored, there was a “rescue” vasoconstriction, indicating that elements of the NOS system, downstream from the enzyme itself, are also inhibited by local cooling. Adapted, with permission, From Hodges et al. (159).
Figure 22. Figure 22. Summary of the mechanisms currently thought to participate in the cutaneous vascular response to local skin cooling. Included in this synthesis are a transient vasodilator response via an unknown mechanism, alpha2c receptor translocation from the Golgi to the smooth cell membrane via a Rho/Rho kinase stimulation, an inhibition of NOS and elements on that system downstream from NOS and an unknown involvement of cold sensitive afferents.
Figure 23. Figure 23. Illustration of threshold shifts in the skin blood flow‐internal temperature relationship. (A) During the development of reflex changes in skin blood flow during whole body heating under control conditions, there is an abrupt increase in skin blood flow after internal temperature reaches a threshold of approximately 37°C. (B) The internal temperature threshold for vasodilation is increased. This occurs during the luteal phase of the menstrual cycle or with oral contraceptive use. (C) The internal temperature threshold for vasodilation is decreased. This is observed during estrogen replacement therapy). The postthreshold sensitivity of responses A through C, that is, the slope of the skin blood flow‐internal temperature relationship, does not change. Adapted, with permission, From Charkoudian (48).
Figure 24. Figure 24. Increase in ΔSkBF from baseline to limits of thermal tolerance during direct passive heating, calculated as sum of increase in cardiac output (Q·c) from baseline and total blood flow redistributed from splanchnic (SBF) and renal (RBF) circulations: ΔSkBF = ΔQ·c + ΔSBF + ΔRBF. Numerical values are means ± SE for total ΔSkBF; n = 7/group. *Significantly different from young men (p < 0.01); (289).
Figure 25. Figure 25. Cutaneous vascular conductance responses during the plateau in skin blood flow heat stress in young and older persons. Cutaneous vasodilation was attenuated at untreated control sites and NOS‐inhibited sites in older subjects. Arginase inhibition, L‐arginine supplementation, and arginase inhibition with L‐arginine supplementation augmented in older but not young persons. Adapted, with permission, from Holowatz et al. (170).
Figure 26. Figure 26. Vasoconstrictor responses to LBNP in normothermic and hyperthermic conditions. The upper panel shows CVC responses from a site pretreated with bretylium to block vasoconstrictor nerve function. The middle panel shows data from an unblocked, control site. Three bouts of LBNP were performed (upper line, bottom panel). Cold stress was used to test for the adequacy of vasoconstrictor nerve block (solid squares and rectangles). The key features are that bretylium blocked the vasoconstrictor responses to body cooling and to LBNP in normothermia, but did not block the response to LBNP in hyperthermia. This finding indicates the cutaneous vasoconstriction (reduced CVC) with LBNP in hyperthermia is via inhibition of the active vasodilator system. Adapted, with permission, from Kellogg et al. (220).
Figure 27. Figure 27. Role of the active vasodilator system in the increased threshold internal temperature with dynamic exercise. CVC data are from rest (left two collections of square symbols) and exercise (right collections of circle symbols). Filled symbols indicate pretreatment with bretylium to block vasoconstrictor nerve function. Threshold was determined as the internal temperature (Tes) at which CVC began to increase. Both at rest and with exercise, the threshold for vasodilation did not differ between untreated control sites and sites pretreated with bretylium. However, the threshold for vasodilation was increased in both cases by exercise. This indicates the increased threshold to be an influence of exercise on the control of the vasodilator system. Adapted, with permission, from Kellogg et al. (222).
Figure 28. Figure 28. Responses in CVC measure from glabrous (palm and sole) and nonglabrous (forearm and leg) to isometric handgrip exercise (IHG) and isometric leg extension (ILE). Either form of isometric exercise caused a prompt and significant vasoconstriction in glabrous skin but no significant responses were seen in nonglabrous skin. Adapted, with permission, from Saad et al. (336).


Figure 1. Summary of the changes in cardiac output and its distribution during whole body heat stress in resting subjects. Note that the blood flow to the major visceral circulations is reduced at a time cardiac output is significantly increased, indicating the average increase in blood flow to skin equaled or exceeded 7.8 L·min−1. Adapted, with permission, from Rowell (331).


Figure 2. Edholm et al. (92) demonstrated that thermoregulatory reflex vasodilation was dependent on neural activation by anaesthetizing the cutaneous nerves after activating the heat stress response by whole body heating. Forearm blood flow was measured in each forearm under normothermic conditions. Heat stress was then induced and when forearm blood flow had increased and stabilized, the skin of one forearm was anesthetized with lidocaine injections and forearm blood flow measurements continued. The upper three figures show the effect of cutaneous nerve block performed during whole body heating after forearm blood flow has increased. Control experiments were performed with saline in lieu of lidocaine. The results of this substitution are shown in the lower three figures.


Figure 3. Response in forearm skin blood flow to local and combined local and whole body heating, as functions of internal temperature (Tes). The filled symbols are from the arm initially warmed to 42°C. The open symbols are from the arm maintained at 34°C throughout. While the arms were at those temperatures, the subject underwent whole body heat stress. Note that the blood flow in the two arms reached the same level, indicating that either local warming to 42°C or the reflex response to whole body heat stress can maximally vasodilate the skin. Adapted, with permission, from Taylor et al. (399).


Figure 4. Responses in forearm blood flow and esophageal temperature to small cycles in whole body skin temperature. The data in the upper panel are from a forearm that was maintained at a neutral temperature throughout and the data in the second panel are from a forearm that had the surface temperature cycle with skin temperature. The vasoconstrictor response to the approximately 2°C reductions in skin temperature was sufficient to limit heat loss and cause internal temperature to increase. In this range, the response was almost entirely due to reflex vasoconstriction, as the variation in local temperature did not notably affect the response. Adapted, with permission, from Savage and Brengelmann (342).


Figure 5. Responses in cutaneous vascular conductance (CVC) to changes in internal temperature caused by mild exercise. Whole body skin temperature (Tsk) and local temperature at the site of blood flow measurement (Tloc) were independently controlled in a series of four experiments in which one or the other was cooled. The open symbols are data from control skin sites and the filled symbols are from skin sites pretreated with the antiadrenergic compound bretylium. Note that a cool Tsk shifts the relationship to a higher threshold and that shift is unaffected by vasoconstrictor nerve blockade (panels A vs. C). Note also that local cooling does not have any obvious effect on the threshold, but does reduce the sensitivity of the CVC‐esophageal temperature relationship and that reduction in sensitivity is reversed by vasoconstrictor nerve blockade. Adapted, with permission, from Pérgola et al. (308).


Figure 6. (A) Example of the effects of NOS blockade with L‐NAME on responses to cold stress (CS1 and CS2), whole body heating, and sodium nitroprusside infusion (SNP). Cutaneous vascular responses to cold stress were unaltered by L‐NAME treatment; however, the increase in cutaneous vascular conductance during whole body heating was attenuated. Sweat rate response was unaltered by L‐NAME. Adapted, with permission, from Kellogg et al. (216). (B) Example of cutaneous vascular conductance responses to intra‐arterial infusion of Ach, L‐NMMA, and nitroprusside (NTP) during whole body heating. Cutaneous vascular responses to whole body heating were attenuated by L‐NMMA infusion indicating that NO participates in cutaneous active vasodilation. Adapted, with permission, from Shastry et al. (351).


Figure 7. Influence of antagonism of nNOS via intradermal 7‐NI on the vasodilator response to whole body heating and (top panel) and to direct skin warming (lower panel). Note that the reflex effects were significantly reduced, whereas the response to direct local warming was unaffected. Adapted, with permission, from Kellogg et al. (231).


Figure 8. Effect of intradermal botulinum toxin on cutaneous active vasodilation, vasoconstriction, and sweating from one subject. The top panel shows sweating responses at an untreated site and at a botulinum toxin‐treated site. The lower panel shows cutaneous vascular conductance responses recorded simultaneously from the same sites as sweating. Periods of whole‐body cold stress (min 10‐13), whole‐body heating (min 26‐63), and local warming of the LDF sites (min 72‐112) are indicated. During cold stress, there was a fall in CVC at both sites, demonstrating cutaneous vasoconstriction. During heat stress, the untreated site showed a typical cutaneous vasodilation. No vasodilation occurred at the site pretreated with botulinum toxin. Sweating occurred at the untreated site, but not at the botulinum toxin‐treated site. These results indicate that cholinergic nerves mediate cutaneous active vasodilation. Given the results from atropinization above, this result demonstrates that mediation is via release of a cotransmitter. Adapted, with permission, from Kellogg et al. (227).


Figure 9. Evidence that VIP may affect a portion of cutaneous active vasodilation. Forearm sites were treated with atropine, the antagonist VIP(10‐28), both antagonists, or Ringer solution only. (A) The magnitude of the change in cutaneous vascular conductance during the last 2 min of whole body heating was not statistically different among treatment sites (‡p = 0.08); however, one subject displayed a dramatic, unexplained vasodilatation during the last 7 min of heat stress at the VIP(10‐28)‐treatment site only. (B) With this subject removed, VIP(10‐28) reduced the vasodilator response significantly Atropine did not significantly affect the magnitude of the vasodilation (15).


Figure 10. The effect of NK1 receptor desensitization on the plateau in skin blood flow achieved during whole‐body heating. The vasodilator response to whole body heating was significantly reduced in sites where substance P pretreatment was given when compared to untreated control sites. NOS inhibited sites that received L‐NAME only were attenuated compared to both untreated control sites and substance P desensitized sites. Responses at sites pretreated with substance P and L‐NAME were significantly reduced compared to all other sites. Adapted, with permission, from Wong and Minson (448).


Figure 11. Effect of TRPV1 channel antagonism with capsazepine, NOS blockade with L‐NAME, and combined TRPV1 and NOS during whole body heating as a function of increasing oral temperature (Tor). Cutaneous vascular conductance increases at sites treated capsazepine, L‐NAME, and combined capsazepine/L‐NAME sites were attenuated compared to untreated control sites. L‐NAME treatment whether with or without capsazepine produced similar degrees of attenuation. These results indicate that TRPV‐1 channels affect a portion of cutaneous active vasodilation and involve NO generation by NOS. Adapted, with permission, from Wong and Fieger (447).


Figure 12. An example of the effect of cyclooxygenase antagonism by ketorolac (KETO) with and without NOS blockade by L‐NAME on cutaneous vascular conductance responses to whole body heating. In normothermia, cutaneous vascular conductance did not differ among sites. In response to whole body heating cutaneous vascular conductance at all treated sites was significantly attenuated when compared to untreated control sites. Cutaneous vascular conductance at the combined KETO and L‐NAME site was significantly attenuated when compared to sites treated with KETO or L‐NAME alone. These results are consistent with involvement of the cyclooxygenase pathway in cutaneous active vasodilation through NO‐independent mechanisms. Adapted, with permission, from McCord et al. (279).


Figure 13. Summary of the Mechanisms Contributing to Active Vasodilation. In the left panel, a typical tracing of the skin blood flow response to whole body heating is presented, displaying baseline skin blood flow (expressed as percent of maximal cutaneous vascular conductance), the initial rise in skin blood flow representing release of tonic vasoconstrictor tone, and the subsequent rise in skin blood flow attributed to active vasodilation by sympathetic cholinergic nerves. In the right panel, a schematic of the current theory of cutaneous active vasodilation is presented. Acetylcholine (Ach) is released and contributes to the early rise in cutaneous active vasodilation and causes a simultaneous activation of sweat glands. The purported cotransmitters with Ach include vasoactive intestinal peptide (VIP) and/or pituitary adenylate cyclase‐activating peptide (PACAP). These will then bind to the pituitary adenylate cyclase‐activating peptide 1 receptor (PAC1) or the vasoactive intestinal peptide receptor 1 or 2 (VPAC1 or VPAC2). Evidence suggests a potential role for histamine acting via histamine‐1 receptors (H1), as well as activation of transient receptor potential vanilloid receptor 1 (TRPV‐1). These two pathways [and Ach via muscarinic receptor‐ 3 (M3)] appear to work through nitric oxide (NO) to contribute up to 40% to 50% of active vasodilation. Recent evidence demonstrates it is the neural NO synthase (nNOS) isoform. In addition, prostacyclin (PGI2) contributes to active vasodilation via the cyclooxygenase pathway (COX). A role for substance P via the neurokinin‐1 receptor (NK1) has also been described, although the specific mechanisms of this pathway have not been determined.


Figure 14. (A) Vasoconstrictor responses to reductions in whole body skin temperature from skin sites treated with the Y1 NPY receptor antagonist BIBP‐3226 (upper curve) or with Ringer's solution (lower curve), both by microdialysis. The NPY receptor antagonist inhibited the vasoconstrictor response. (B) Response to reduced whole body skin temperature at skin sites treated with Ringer's (control), Yohimbine and Propranolol (adrenergic antagonism) and Yohimbine, Propranolol plus BIBP‐3226 for adrenergic and NPY Y1 receptor blockade. Note that either adrenergic receptor blockade or NPY receptor blockade reduced the vasoconstrictor response to cooling, and that the combination eliminated the response, indicating a cotransmitter role for NPY in reflex cutaneous vasoconstriction. Adapted, with permission, from Stephens et al. (372).


Figure 15. Summary of the Mechanisms Contributing to Thermal Hyperemia. In the top left of the figure, a typical tracing of the skin blood flow response to rapid local heating to 42°C is presented, displaying an Initial Peak, a subsequent drop to a Nadir, and a further vasodilation to a sustained Plateau. This is often followed by an attenuation of the Plateau phase during the “die‐away” phenomenon. The middle figure displays the current theory behind the vasodilation to local heating during the Initial Peak, and the bottom figure displays the current theory behind vasodilation during the Plateau Phase. In both figures, pathways in the endothelium and the smooth muscle are presented. Roles for both sensory/nociceptive nerves releasing substance P (SP) and calcitonin gene‐related peptide (CGRP) and adrenergic nerves releasing norepinephrine (NE) and neuropeptide Y (NPY) are also shown. In both phases, vasodilation occurs through complex pathways that lead to the production of NO and smooth muscle relaxation via hyperpolarization from endothelial derived hyperpolarization factors (EDHFs). Potential sources of endothelial derived NO identified to date include the transient receptor peptide TRPV1, the adenosine receptors (A1 and A2), NK1‐receptor activation by SP, CGRP, and β2 receptor activation. Potential EDHFs include the epoxyeicosatrienoic acids (EETs), the lipoxygenase (LOX) derivatives 12‐(S)‐hydroxyeicosatetraenoic acid (12‐S‐HETE) and 11,12,15‐trihydroxyeicosatrienoic acid (11,12,15‐THETA), and H2O2.


Figure 16. Responses in CVC to slow local heating (panel A) and rapid local heating (panel B) from control sites and sites pretreated with bretylium (BT). Slow local heating causes an axon reflex (*). Under conditions of adrenergic blockade with BT, the axon reflex was abolished and a lower peak vasodilator response achieved. Rapid local heating caused a more pronounced axon reflex and a greater peak vasodilator response at the untreated site. Pretreatment with BT reduced (p < 0.05) but did not abolish the axon reflex to rapid heating. BT also causes an attenuated peak vasodilator response to local heating. The untreated sites showed a decline in CVC following rapid heating. This “die away” phenomenon was abolished by pretreatment with BT. †p < 0.05, CVC at these points is significantly higher at the untreated sites compared with that at the BT treated sites for that heating protocol. From Hodges et al. (157).


Figure 17. NOS isoforms and the responses to local skin warming. At a local skin temperature (Tloc) of 34°C, CVC values, normalized to their respective maxima, did not differ significantly among untreated, LNAA treated (eNOS antagonist), NPLA treated (nNOS antagonist) or their combination. CVC increased in response to local skin warming at all sites but that increase was significantly inhibited at the site with eNOS antagonism (228).


Figure 18. Representative tracing during local heating to 42°C from one subject from Brunt and Minson (41). Four microdialysis sites were infused with Ringer solution (Control), tetraethylammonium (TEA), NG‐nitro‐l‐arginine methyl ester (L‐NAME), and TEA+L‐NAME. Data are expressed as a percent of maximal CVC obtained from infusion of 56 mmol/L sodium nitroprusside. Initial Peak, Nadir, and Plateau phase responses were all reduced with TEA (to block calcium‐activated potassium channels; KCa). Combined blockade with TEA and L‐NAME nearly abolished all vasodilation during local heating, demonstrating that KCa channels have a profound role in the Initial Peak response to local heating, and account for the remaining ∼40% of vasodilation during the Plateau phase not inhibited by NO‐synthase inhibition alone (41).


Figure 19. (A) Effects of blockade of adrenergic receptors with yohimbine and propranolol (Y + P), the rho kinase inhibitor fasudil and their combination on the vasoconstrictor response to locally applied norepinephrine. (B) The effects of the same antagonists on the vasoconstrictor response to local skin cooling. Either antagonist reduced, but did not eliminate the response. Importantly, the combination of Y+P+ fasudil did not have an effect greater than that by fasudil alone, suggesting the adrenergic portion of the response to local skin cooling was through the rho kinase system. Adapted, with permission, from Thompson‐Torgerson et al. (407).


Figure 20. Effect of local treatment of skin with ascorbic acid on the vasoconstrictor response to local cooling (reduced Tloc at 0 min) and to reduced whole body skin temperature (Mean Tsk). Note that the vasoconstrictor response to local skin cooling was reduced by ascorbic acid treatment, suggesting a role for reactive oxygen species in the control response. Adapted, with permission, From Yamazaki (456).


Figure 21. Role of adrenergic nerves and NOS in the cutaneous vascular response to local skin cooling from 34 to 24°C. Sites were pretreated with bretylium to eliminate transmitter release from vasoconstrictor nerve terminals. NOS were inhibited at both sites, beginning at min 20, causing a vasoconstriction to develop over the next 35 min. At one site, NO and basely e CVC were restored via exogenous sodium nitroprusside (SNP; filled symbols). Local cooling was then applied to both sites between min 85 and 115. Note that in the site without exogenous SNP (open symbols), there was no vasoconstrictor response to local cooling, indicating the normal vasoconstrictor response to be dependent on a combination of NOS inhibition and adrenergic activation. At the site with NO and baseline blood flow restored, there was a “rescue” vasoconstriction, indicating that elements of the NOS system, downstream from the enzyme itself, are also inhibited by local cooling. Adapted, with permission, From Hodges et al. (159).


Figure 22. Summary of the mechanisms currently thought to participate in the cutaneous vascular response to local skin cooling. Included in this synthesis are a transient vasodilator response via an unknown mechanism, alpha2c receptor translocation from the Golgi to the smooth cell membrane via a Rho/Rho kinase stimulation, an inhibition of NOS and elements on that system downstream from NOS and an unknown involvement of cold sensitive afferents.


Figure 23. Illustration of threshold shifts in the skin blood flow‐internal temperature relationship. (A) During the development of reflex changes in skin blood flow during whole body heating under control conditions, there is an abrupt increase in skin blood flow after internal temperature reaches a threshold of approximately 37°C. (B) The internal temperature threshold for vasodilation is increased. This occurs during the luteal phase of the menstrual cycle or with oral contraceptive use. (C) The internal temperature threshold for vasodilation is decreased. This is observed during estrogen replacement therapy). The postthreshold sensitivity of responses A through C, that is, the slope of the skin blood flow‐internal temperature relationship, does not change. Adapted, with permission, From Charkoudian (48).


Figure 24. Increase in ΔSkBF from baseline to limits of thermal tolerance during direct passive heating, calculated as sum of increase in cardiac output (Q·c) from baseline and total blood flow redistributed from splanchnic (SBF) and renal (RBF) circulations: ΔSkBF = ΔQ·c + ΔSBF + ΔRBF. Numerical values are means ± SE for total ΔSkBF; n = 7/group. *Significantly different from young men (p < 0.01); (289).


Figure 25. Cutaneous vascular conductance responses during the plateau in skin blood flow heat stress in young and older persons. Cutaneous vasodilation was attenuated at untreated control sites and NOS‐inhibited sites in older subjects. Arginase inhibition, L‐arginine supplementation, and arginase inhibition with L‐arginine supplementation augmented in older but not young persons. Adapted, with permission, from Holowatz et al. (170).


Figure 26. Vasoconstrictor responses to LBNP in normothermic and hyperthermic conditions. The upper panel shows CVC responses from a site pretreated with bretylium to block vasoconstrictor nerve function. The middle panel shows data from an unblocked, control site. Three bouts of LBNP were performed (upper line, bottom panel). Cold stress was used to test for the adequacy of vasoconstrictor nerve block (solid squares and rectangles). The key features are that bretylium blocked the vasoconstrictor responses to body cooling and to LBNP in normothermia, but did not block the response to LBNP in hyperthermia. This finding indicates the cutaneous vasoconstriction (reduced CVC) with LBNP in hyperthermia is via inhibition of the active vasodilator system. Adapted, with permission, from Kellogg et al. (220).


Figure 27. Role of the active vasodilator system in the increased threshold internal temperature with dynamic exercise. CVC data are from rest (left two collections of square symbols) and exercise (right collections of circle symbols). Filled symbols indicate pretreatment with bretylium to block vasoconstrictor nerve function. Threshold was determined as the internal temperature (Tes) at which CVC began to increase. Both at rest and with exercise, the threshold for vasodilation did not differ between untreated control sites and sites pretreated with bretylium. However, the threshold for vasodilation was increased in both cases by exercise. This indicates the increased threshold to be an influence of exercise on the control of the vasodilator system. Adapted, with permission, from Kellogg et al. (222).


Figure 28. Responses in CVC measure from glabrous (palm and sole) and nonglabrous (forearm and leg) to isometric handgrip exercise (IHG) and isometric leg extension (ILE). Either form of isometric exercise caused a prompt and significant vasoconstriction in glabrous skin but no significant responses were seen in nonglabrous skin. Adapted, with permission, from Saad et al. (336).
References
 1.Allwood MJ, Burry HS. The effect of local temperature on blood flow in the human foot. J Physiol 124: 345‐357, 1954.
 2.Alvarez GE, Zhao K, Kosiba WA, Johnson JM. Relative roles of local and reflex components in cutaneous vasoconstriction during skin cooling in humans. J Appl Physiol 100: 2083‐2088, 2006.
 3.Anderson C, Andersson T, Wardell K. Changes in skin circulation after insertion of a microdialysis probe visualized by laser‐Doppler perfusion imaging. J Invest Dermatol 102: 808‐811, 1994.
 4.Anderssohn M, Schwedhelm E, Lüneburg N, Vasan RS, Böger RH. Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus. Diab Vasc Dis Res 7: 105‐118, 2010.
 5.Andersson SE, Edvinsson ML, Alving K, Edvinsson L. Vasodilator effect of endothelin in cutaneous microcirculation of heart failure patients. Basic Clin Pharmacol Toxicol 97: 80‐85, 2005.
 6.Aoki K, Stephens DP, Zhao K, Kosiba WA, Johnson JM. Modification of cutaneous vasodilator response to heat stress by daytime exogenous melatonin administration. Am J Physiol Regul Integr Comp Physiol 291: R619‐R624, 2006.
 7.Aoki K, Zhao K, Yamazaki F, Sone R, Alvarez GE, Kosiba WA, Johnson JM. Exogenous melatonin administration modifies cutaneous vasoconstrictor response to whole body skin cooling in humans. J Pineal Res 44: 141‐148, 2008.
 8.Aschoff J. Hauttemperatur und Hautdurchblutung im Dienst der Temperatur‐regulation. Klin Wochenschr 36: 193‐202, 1958.
 9.Bailey SR, Eid AH, Mitra S, Flavahan S, Flavahan NA. Rho kinase mediates cold‐induced constriction of cutaneous arteries. Circ Res 94: 1367‐1374, 2004.
 10.Bailey SR, Mitra S, Flavahan S, Flavahan NA. Reactive oxygen species from smooth muscle mitochondria initiate cold‐induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289: H253‐H250, 2005.
 11.Barcroft H, Edholm OG. The effect of temperature on blood flow and deep temperature in the human forearm. J Physiol (London) 102: 5‐20, 1943.
 12.Behnke A R, Willmon TL. Cutaneous diffusion of helium in regulation to peripheral blood flow and the absorption of atmospheric nitrogen through the skin. Am J Physiol 131: 627‐632, 1940.
 13.Beiser GD, Zelis R, Epstein SE, Mason DT, Braunwald E. The role of skin and muscle resistance vessels in reflexes mediated by the baroreceptor system. J Clin Invest 49: 225‐231, 1970.
 14.Beleznai T, Feher A, Spielvogel D, Lansman SL, Bagi Z. Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes. Am J Physiol Heart Circ Physiol 300: H777‐H783, 2011.
 15.Bennett LAT, Johnson JM, Stephens DP, Saad AR, Kellogg DL, Jr. Evidence for a role for vasoactive intestinal peptide in active vasodilation in the cutaneous vasculature in humans. J Physiol (London) 552: 223‐232, 2003.
 16.Benzinger TH. Peripheral cold‐ and central warm‐reception, main origins of human thermal discomfort. Proc Natl Acad Sci U S A 49: 832‐839, 1963.
 17.Benzinger TH. Heat regulation: Homeostasis of central temperature in man. Physiol Rev 49: 671‐759, 1969.
 18.Bergersen TK, Eriksen M, Walloe L. Effect of local warming on hand and finger artery blood velocities. Am J Physiol 269: R325‐R330, 1995.
 19.Bier A. Die Entstehung des Collateralkreislaufs. Thiel I. Der arterielle Collateralkreislauf. Archiv für Path Anat Physiol Klin Med 147: 256‐293, 1897.
 20.Binggeli C, Spieker LE, Corti R, Sudano I, Stojanovic V, Hayoz D, Luscher TF, Noll G. Statins enhance postischemic hyperemia in the skin circulation of hypercholesteremic patients. J Am Coll Cardiol 42: 71‐77, 2003.
 21.Boels PJ, Verbeuren TJ, Vanhoutte PM. Moderate cooling depresses the accumulation and the release of newly synthesized catecholamines in isolated canine saphenous veins. Experientia 41: 1374‐1377, 1985.
 22.Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium‐dependent potassium channels in vascular smooth muscle. Nature 368: 850‐853, 1994.
 23.Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U. Nitric oxide‐induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation 107: 3081‐3087, 2003.
 24.Bonner R, Nossal R. Model for laser Doppler measurements of blood flow in tissue. Appl Optics 20: 2097‐2107, 1981.
 25.Bonner RF, Nossal R, Havlin S, Weiss GH. Model for photon migration in turbid biological media. J Opt Soc Am A 4: 423‐432, 1987.
 26.Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 119: 1592‐1600, 2009.
 27.Brain SD, Williams TJ. Substance P regulates the vasodilator activity of calcitonin gene‐related peptide. Nature 335: 73‐75, 1988.
 28.Braverman IM. The cutaneous microcirculation: Ultrastructure and microanatomical organization. Microcirculation 4: 329‐340, 1997.
 29.Breidenbach MA, Brunger AT. New insights into clostridial neurotoxin‐SNARE interactions. Trends Mol Med 11: 377‐381, 2005.
 30.Brengelmann GL, Freund PR, Rowell LB, Olerud JE, Kraning KK. Absence of active vasodilation associated with congenital absence of sweat glands in humans. Am J Physiol 240: H571‐H575, 1981.
 31.Brengelmann GL, Johnson JM, Hermansen L, Rowell LB. Altered control of skin blood flow during exercise at high internal temperatures. J Appl Physiol 43: 790‐794, 1977.
 32.Brengelmann GL, Savage MV. Temperature regulation in the neutral zone. Ann NY Acad Sci 813: 39‐50, 1997.
 33.Briers JD. Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Meas 22: R35‐R66, 2001.
 34.Brodie TG, Russell AE. On the determination of the rate of blood flow through an organ. J Physiol 32: 47‐49, 1905.
 35.Brothers RM, Wingo JE, Hubing KA, Crandall CG. Methodological assessment of skin and limb blood flows in the human forearm during thermal and baroreceptor provocations. J Appl Physiol 109: 895‐900, 2010.
 36.Brown MG, Morice AH. Clinical pharmacology of vasodilator peptides. J Cardiovasc Pharmcol 10: S82‐S85, 1987.
 37.Brunger AT, Jin R, Breidenbach MA. Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins. Cell Mol Life Sci 65: 2296‐2306, 2008.
 38.Bruning RS, Santhanam L, Stanhewicz AE, Smith CJ, Berkowitz DE, Kenney WL, Holowatz LA. Endothelial nitric oxide synthase mediates cutaneous vasodilation during local heating and is attenuated in middle‐aged human skin. J Appl Physiol 112: 2019‐2026, 2012.
 39.Brunt VE, Fujii N, Minson CT. No independent, but an interactive, role of calcium‐activated potassium channels in human cutaneous active vasodilation. J Appl Physiol 115: 1303‐1309, 2013.
 40.Brunt VE, Miner JA, Meendering JR, Kaplan PF, Minson CT. 17β‐estradiol and progesterone independently augment cutaneous thermal hyperemia but not reactive hyperemia. Microcirculation 18: 347‐355, 2011.
 41.Brunt VE, Minson CT. KCa channels and epoxyeicosatrienoic acids: Major contributors to thermal hyperaemia in human skin. J Physiol 590: 3523‐3534, 2012.
 42.Burnstock G. Purinergic cotransmission. Brain Res Bull 50: 355‐357, 1999.
 43.Burton AC. The range and variability of the blood flow in the human fingers and the vasomotor regulation of body temperature. Am J Physiol 127: 437‐453, 1939.
 44.Burton AC, Patel DJ. Reactive hyperemia in the human finger. Circ Res 4: 710‐712, 1956.
 45.Carberry PA, Shepherd AM, Johnson JM. Resting and maximal forearm skin blood flows are reduced in hypertension. Hypertension 20: 349‐355, 1992.
 46.Cardounel AJ, Xia Y, Zweier JL. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric‐oxide synthase: Differences in the effects of monomethyl‐ and dimethylarginines in the presence and absence of tetrahydrobiopterin. J Biol Chem 280: 7540‐7549, 2005.
 47.Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat‐activated ion channel in the pain pathway. Nature 389: 816‐824, 1997.
 48.Charkoudian N. Influences of female reproductive hormones on sympathetic control of the circulation in humans. Clin Auton Res 11: 295‐301, 2001.
 49.Charkoudian N. Skin blood flow in adult human thermoregulation: How it works, when it does not, and why. Mayo Clin Proc 78: 603‐612, 2003.
 50.Charkoudian N. Mechanisms and modifiers of reflex induced cutaneous vasodilation and vasoconstriction in humans. J Appl Physiol 109: 1221‐1228, 2010.
 51.Charkoudian N, Eisenach JH, Atkinson JLD, Fealey RD, Joyner MJ. Effects of chronic sympathectomy on locally mediated cutaneous vasodilation in humans. J Appl Physiol 92: 685‐690, 2002.
 52.Charkoudian N, Fromy B, Saumet JL. Reflex control of the cutaneous circulation after acute and chronic local capsaicin. J Appl Physiol 90: 1860‐1864, 2001.
 53.Charkoudian N, Johnson JM. Modification of active cutaneous vasodilation by oral contraceptive hormones. J Appl Physiol 83: 2012‐2018, 1997.
 54.Charkoudian N, Johnson JM. Reflex control of cutaneous vasoconstrictor system is reset by exogenous female reproductive hormones. J Appl Physiol 87: 381‐385, 1999.
 55.Charkoudian N, Johnson JM. Female reproductive hormones and thermoregulatory control of skin blood flow. Exercise Sports Sci Rev 28: 108‐112, 2000.
 56.Charkoudian N, Stephens DP, Pirkle KC, Kosiba WA, Johnson JM. Influence of female reproductive hormones on local thermal control of skin blood flow. J Appl Physiol 87: 1719‐1723, 1999.
 57.Chotani MA, Flavahan S, Mitra S, Daunt D, Flavahan NA. Silent α2c‐adrenergic receptors enable cold‐induced vasoconstriction in cutaneous arteries. Am J Physiol 278: H1075‐H1083, 2000.
 58.Christensen EH, Nielsen M, Hannisdahl B. Investigations of the circulation in the skin at the beginning of muscular work. Acta Physiol Scand 4: 162‐170, 1942.
 59.Colberg SR, Parson HK, Nunnold T, Holton DR, Swain DP, Vinik AI. Change in cutaneous perfusion following 10 weeks of aerobic training in Type 2 diabetes. J Diabetes Complications 19: 276‐283, 2005.
 60.Cooke JP, Shepherd JT, Vanhoutte PM. The effect of warming on adrenergic neurotransmission in canine cutaneous vein. Circ Res 54: 547‐553, 1984.
 61.Cooper KE, Cross KW. A comparison of methods for gauging the blood flow through the hand. Clin Sci (Lond) 8: 217‐234, 1949.
 62.Cooper KE, Edholm OG, Mottram RF. The blood flow in skin and muscle of the human forearm. J Physiol 128: 258‐267, 1955.
 63.Coyle EF, González‐Alonso J. Cardiovascular drift during prolonged exercise: New perspectives. Exerc Sport Sci Rev 29: 88‐92, 2001.
 64.Crabtree MJ, Smith CL, Lam G, Goligorsky MS, Gross SS. Ratio of 5,6,7,8‐tetrahydrobiopterin to 7,8‐dihydrobiopterin in endothelial cells determines glucose‐elicited changes in NO vs. superoxide production by eNOS. Am J Physiol Heart Circ Physiol 294: H1530‐H1540, 2008.
 65.Cracowski JL, Minson CT, Salvat‐Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends in Pharmacol Sci 27: 503‐508, 2006.
 66.Cracowski JL, Gaillard‐Bigot F, Cracowski C, Roustit M, Millet C. Skin microdialysis coupled with laser speckle contrast imaging to assess microvascular reactivity. Microvasc Res 82: 333‐338, 2011.
 67.Cracowski JL, Gaillard‐Bigot F, Cracowski C, Sors C, Roustit M, Millet C. Involvement of cytochrome epoxygenase metabolites in cutaneous postocclusive hyperemia in humans. J Appl Physiol 114: 245‐251, 2013.
 68.Crandall CG, Etzel RA, Johnson JM. Evidence of functional Beta‐receptors in the cutaneous vasculature. Am J Physiol 273: H1038‐H1043, 1997.
 69.Crandall CG, Johnson JM, Kosiba WA, Kellogg DL, Jr. Baroreceptor control of the cutaneous active vasodilator system. J Appl Physiol 81: 2192‐2198, 1996.
 70.Crandall CG, MacLean DA. Cutaneous interstitial nitric oxide concentration does not increase during heat stress in humans. J Appl Physiol 90: 1020‐1024, 2001.
 71.Crandall CG, Musick J, Hatch JP, Kellogg DL, Jr, Johnson JM. Cutaneous vascular and sudomotor responses to isometric exercise in humans. J Appl Physiol 79: 1946‐1950, 1995.
 72.Crandall CG, Shibasaki M, Yen TC. Evidence that the human cutaneous venoarteriolar response is not mediated by adrenergic mechanisms. J Physiol 538: 599‐605, 2002.
 73.Crossley RJ, Greenfield AD, Plassaras GC, Stephens D. The interrelation of thermoregulatory and baroreceptor reflexes in the control of the blood vessels in the human forearm. J Physiol 183: 628‐636, 1966.
 74.Cui J, Arbab‐Zadeh A, Prasad A, Durand S, Levine BD, Crandall CG. Effects of heat stress on thermoregulatory responses in congestive heart failure patients. Circulation 112: 2286‐2292, 2005.
 75.Cui J, Boehmer JP, Blaha C, Lucking R, Kunselman AR, Sinoway LI. Chronic heart failure does not attenuate the total activity of sympathetic outflow to skin during whole body heating. Circulation: Heart Failure 6: 271‐278, 2013.
 76.Daanen HAM. Finger cold‐induced vasodilation: A review. Eur J Appl Physiol 89: 411‐426, 2003.
 77.Dalle‐Ave A, Kubli S, Golay S, Delachaux A, Liaudet L, Waeber B, Feihl F. Acetylcholine‐induced vasodilation and reactive hyperemia are not affected by acute cyclo‐oxygenase inhibition in human skin. Microcirculation 11: 327‐336, 2004.
 78.Dalsgaard CJ, Jernbeck J, Stains W, Kjartansson J, Haegerstrand A, Hökfelt T, Brodin E, Cuello AC, Brown JC. Calcitonin gene‐related peptide‐like immunoreactivity in nerve fibers in the human skin. Relation to fibers containing substance P‐, somatostatin‐ and vasocactive intestinalpolypeptide‐like immunoreactivity. Histochemistry 91: 35‐38, 1989.
 79.Dalsgaard CJ, Rydh M, Haegerstrand A. Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 92: 385‐390, 1989.
 80.Detry J‐R, Brengelmann GL, Rowell LB, Wyss C. Skin and muscle components of forearm blood flow in directly heated resting man. J Appl Physiol 32: 506‐511, 1972.
 81.Dhillon S. Bosentan: A review of its use in the management of digital ulcers associated with systemic sclerosis. Drugs 69: 2005‐2024, 2009.
 82.Dietz NM, Rivera JM, Warner DO, Joyner MJ. Is nitric oxide involved in cutaneous vasodilation during body heating in humans? J Appl Physiol 76: 2047‐2053, 1994.
 83.Dolly JO, Aoki KR. The structure and mode of action of different botulinum toxins. Eur J Neurol 13: 1‐9, 2006.
 84.Druhan LJ, Forbes SP, Pope AJ, Chen CA, Zweier JL, Cardounel AJ. Regulation of eNOS‐derived superoxide by endogenous methylarginines. Biochemistry 47: 7256‐7263, 2008.
 85.Drummond PD. Enhancement of thermal hyperalgesia by alpha‐adreoceptors in capsaicin‐treated skin. J Autonom Nervous Sys 69: 96‐102, 1998.
 86.Drummond PD. Alpha(1)‐Adrenoceptors augment thermal hyperalgesia in mildly burnt skin. Eur J Pain 13: 273‐279, 2009a.
 87.Drummond PD. Alpha‐1 adrenoceptor stimulation triggers axon‐reflex vasodilatation in human skin. Autonom Neurosci: Basic Clin 151: 159‐163, 2009b.
 88.Dupont JJ, Farquhar WB, Townsend RR, Edwards DG. Ascorbic acid or L‐arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol 111: 1561‐1567, 2011.
 89.Durand S, Davis SL, Cui J, Crandall CG. Exogenous nitric oxide inhibits sympathetically mediated vasoconstriction in human skin. J Physiol (London) 562: 629‐634, 2005.
 90.Durante W, Johnson FK, Johnson RA. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34: 906‐911, 2007.
 91.Edholm OG, Fox RH, MacPherson RK. The effect of body heating on the circulation in skin and muscle. J Physiol 134: 612‐619, 1956.
 92.Edholm OG, Fox RH, MacPherson RK. Vasomotor control of the cutaneous blood vessels in the human forearm. J Physiol Lond 139: 455‐465, 1957.
 93.Edvinsson L, Ekblad E, Håkanson R, Wahlestedt C. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol 83: 519‐525, 1984.
 94.Edvinsson ML, Andersson SE, Xu CB, Edvinsson L. Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation. Vasc Health Risk Manag 4: 699‐704, 2008.
 95.Edwards CM, Marshall JM, Pugh M. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: The role of endothelin. Clin Sci (Lond) 96: 577‐588, 1999.
 96.Eedy DJ, Shaw C, Armstrong EP, Johnston CF, Buchanan KD. Vasoactive intestinal peptide (VIP) and peptide histidine methionine in human eccrine sweat glands: Demonstration of innervation, specific binding sites and presence in secretions. Br J Dermatol 123: 65‐76, 1990.
 97.Eid AH, Chotani MA, Mitra S, Miller TJ, Flavahan NA. Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle α2c‐adrenoceptors. Am J Physiol Heart Circ Physiol 295: H266‐H272, 2008.
 98.Ekelund LG. Circulatory and respiratory adaptation during prolonged exercise. Acta Physiol Scand Suppl 292: 1‐38, 1967.
 99.Ekenvall L, Lindblad LE, Norbeck O, Etzell BM. α‐Adrenoceptors and cold‐induced vasoconstriction in human finger skin. Am J Physiol Heart Circ Physiol 255: H1000‐H1003, 1988.
 100.Ergul A, Shoemaker K, Puett D, Tackett RT. Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J Pharmacol Exper Ther 285: 511‐517, 1998.
 101.Ettinger SM, Silber DH, Gray KS, Smith MB, Yang QX, Kunselman AR, Sinoway LI. Effects of the ovarian cycle on sympathetic neural outflow during static exercise. J Appl Physiol 85: 2075‐2081, 1998.
 102.Fagius J, Wallin BG, Sundlöf G, Nerhed C, Englesson S. Sympathetic outflow in man after anaesthesia of the glossopharyngeal and vagus nerves. Brain 108(Pt 2): 423‐438, 1985.
 103.Fahrenkrug J, Hannibal J. Neurotransmitters co‐existing with VIP or PACAP. Peptides 25: 393‐401, 2004.
 104.Farrell DM, Bishop VS. Permissive role for nitric oxide in active thermoregulatory vasodilation in rabbit ear. Am J Physiol 269: H1613‐H1618, 1995.
 105.Farrell DM, Bishop VS. The roles of cGMP and cAMP in active thermoregulatory vasodilation. Am J Physiol 272: R975‐R981, 1997.
 106.Félétou M, Vanhoutte PM. EDHF: An update. Clin Sci (Lond) 117: 139‐155, 2009.
 107.Fieger SM, Wong BJ. Adenosine receptor inhibition with theophylline attenuates the skin blood flow response to local heating in humans. Exp Physiol 95: 946‐954, 2010.
 108.Fieger SM, Wong BJ. No direct role for A1/A2 adenosine receptor activation to reflex cutaneous vasodilatation during whole‐body heat stress in humans. Acta Physiol (Oxf) 205: 403‐410, 2012.
 109.Fox RH, Edholm OG. Nervous control of the cutaneous circulation. Br Med Bull 19: 110‐ 114, 1963.
 110.Fox RH, Goldsmith R, Kidd DJ. Cutaneous vasomotor control in the human head, neck and upper chest. J Physiol 161: 298‐312, 1962.
 111.Fox RH, Hilton SM. Bradykinin formation in human skin as a factor in heat vasodilation. J Physiol (London) 142: 219‐232, 1958.
 112.Fredriksson I, Larsson M, Nyström FH, Länne T, Ostgren CJ, Strömberg T. Reduced arteriovenous shunting capacity after local heating and redistribution of baseline skin blood flow in type 2 diabetes assessed with velocity‐resolved quantitative laser Doppler flowmetry. Diabetes 59: 1578‐1584, 2010.
 113.Freedman RR, Girgis R. Effects of menstrual cycle and race on peripheral vascular α‐adrenergic responsiveness. Hypertension 35: 795‐799, 2000.
 114.Freund PR, Brengelmann GL, Rowell LB, Halar E. Attenuated skin blood flow response to hyperthermia in paraplegic men. J Appl Physiol 56: 1104‐1109, 1984.
 115.Frewin DB, McConnell DJ, Downey JA. Is a kininogenase necessary for human sweating? Lancet 2: 744, 1973.
 116.Fujii N, Reinke MC, Brunt VE, Minson CT. Impaired acetylcholine‐induced cutaneous vasodilation in young smokers: Roles of nitric oxide and prostanoids. Am J Physiol Heart Circ Physiol 304: H667‐H673, 2013.
 117.Gagnon D, Jay O, Reardon FD, Journeay WS, Kenny GP. Hyperthermia modifies the nonthermal contribution to postexercise heat loss responses. Med Sci Sports Exerc 40: 513‐522, 2008.
 118.Ganio MS, Overgaard M, Seifert T, Secher NH, Johansson PI, Meyer MA, Crandall CG. Effect of heat stress on cardiac output and systemic vascular conductance during simulated hemorrhage to presyncope in young men. Am J Physiol Heart Circ Physiol 302: H1756‐H1761, 2012.
 119.Garry A, Sigaudo‐Roussel D, Merzeau S, Dumont O, Saumet JL, Fromy B. Cellular mechanisms underlying cutaneous pressure‐induced vasodilation: in vivo involvement of potassium channels. Am J Physiol 289: H174‐H180, 2005.
 120.Gaskell P. Are there sympathetic vasodilator nerves to the vessels of the hands? J Physiol(London) 131: 647‐656, 1956.
 121.Gibbins IL, Jobling P, Morris JL. Functional organization of peripheral vasomotor pathways. Acta Physiol Scand 177: 237‐245, 2003.
 122.Gifford JR, Heal C, Bridges J, Goldthorpe S, Mack GW. Changes in dermal interstitial ATP levels during local heating of human skin. J Physiol 590: 6403‐6411, 2012.
 123.Goldberg MR, Robertson D. Yohimbine: A pharmacological probe for study of the alpha 2‐adrenoreceptor. Pharmacol Rev 35: 143‐180, 1983.
 124.Goldstein DS, Bonner RF, Zimlichman R, Zahn TP, Cannon RO, Rosing DR, Stull R, Keiser HR. Indices of sympathetic vascular innervation in sympathectomized patients. J Auton Nerv Syst 15: 309‐318, 1986.
 125.Gooding KM, Hannemann MM, Tooke JE, Clough GF, Shore AC. Maximum skin hyperaemia induced by local heating: Possible mechanisms. J Vasc Res 43: 270‐277, 2005.
 126.Gori T, Münzel T. Oxidative stress and endothelial dysfunction: Therapeutic implications. Ann Med 43: 259‐272, 2011.
 127.Grant RT, Bland EF. Observations on arteriovenous anastomoses in human skin and in the bird's foot with special reference to the reaction to cold. Heart 15: 1929‐1931, 1931.
 128.Grant RT, Holling HE. Further observations on the vascular responses of the human limb to body warming; evidence for sympathetic vasodilator nerves in the normal subject. Clin Sci 3: 273‐285, 1938.
 129.Green DJ, Maiorana AJ, Siong JH, Burke V, Erickson M, Minson CT, Bilsborough W, O'Driscoll G. Impaired skin blood flow response to environmental heating in chronic heart failure. Eur Heart J 27: 338‐343, 2006.
 130.Greenfield AD. Venous occlusion plethysmography. Methods Med Res 8: 293‐301, 1960.
 131.Greenfield AD, Kernohan GA, Marshall RJ, Shepherd JT, Whelan RF. Heat loss from toes and fore‐feet during immersion in cold water. J Appl Physiol 4: 37‐45, 1951.
 132.Greenfield ADM. The circulation through the skin. In: Hamilton WF, Dow P, editor. Handbook of Physiology, Circulation. Washington, DC: Am. Physiol. Soc., 1963.
 133.Grider JR. Identification of neurotransmitters by selective protection of postjunctional receptors. Am J Physiol 258: G103‐G106, 1990.
 134.Grossmann M, Jamieson MJ, Kellogg DL, Kosiba WA, Pérgola PE, Crandall CG, Shepherd AMM. The effect of iontophoresis on the cutaneous vasculature: Evidence for current‐induced hyperemia. Microvasc Res 50: 444‐452, 1995.
 135.Grucza R, Pekkarinen H, Titov EK, Kononoff A, Hänninen O. Influence of the menstrual cycle and oral contraceptives on thermoregulatory responses to exercise in young women. Eur J Appl Physiol Occup Physiol 67: 279‐285, 1993.
 136.Guy AW, Lehmann JF, Stonebridge JB. Therapeutic applications of electromagnetic power. Proceedings of the IEEE 62: 55‐75, 1974.
 137.Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656‐1662, 2002.
 138.Haeusler G, Haefely W, Huerlimann A. On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn‐Schmiedebergs Arch Pharmak 265: 260‐277, 1979.
 139.Hales JR, Fawcett AA, Bennett JW, Needham AD. Thermal control of blood flow through capillaries and arteriovenous anastomoses in skin of sheep. Pflugers Arch 378: 55‐63, 1978.
 140.Hales JR, Jessen C. Increase of cutaneous moisture loss caused by local heating of the spinal cord in the ox. J Physiol 204: 40P‐42P, 1969.
 141.Hales JR, Jessen C, Fawcett AA, King RB. Skin AVA and capillary dilatation and constriction induced by local skin heating. Pflugers Arch 404: 203‐207, 1985.
 142.Hardy JD, Soderstrom GF. Heat loss from the nude body and peripheral blood flow at temperatures of 22°C to 35°C two figures. J Nutr 16: 493‐510, 1938.
 143.Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Wasachek JA. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide. Pharmacol Rev 50: 265‐270, 1998.
 144.Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol 33: 555‐576, 2001.
 145.Hartschuh W, Reinecke M, Weihe E, Yanaihara N. VIP‐immunoreactivity in the skin of various mammals: Immunohistochemical, radioimmunological, and experimental evidence for a dual localization in cutaneous nerves and Merkel cells. Peptides 5: 239‐245, 1984.
 146.Hashim MA, Tadepalli AS. Cutaneous vasomotor effects of neuropeptide Y. Neuropeptides 29: 263‐271, 1995.
 147.Heath ME. Neuropeptide Y and Y1‐receptor agonists increase blood flow through arteriovenous anastomoses in rat tail. J Appl Physiol 85: 301‐309, 1998.
 148.Heinonen I, Brothers RM, Kemppainen J, Knuuti J, Kalliokoski KK, Crandall CG. Local heating, but not indirect whole body heating, increases human skeletal muscle blood flow. J Appl Physiol 111: 818‐824, 2011.
 149.Heinz‐Erian P, Dey RD, Flux M, Said SI. Deficient vasoactive intestinal peptide innervation in the sweat glands of cystic fibrosis patients. Science 229: 1407‐1408, 1985.
 150.Henning RJ, Sawmiller DR. Vasoactive intestinal peptide: Cardiovascular effects. Cardiovasc Res 49: 27‐37, 2001.
 151.Henriksen O. Local sympathetic reflex mechanism in regulation of blood flow in human subcutaneous adipose tissue. Acta Physiol Scand Suppl 450: 1‐48, 1977.
 152.Herrick AL. Contemporary management of Raynaud's phenomenon and digital ischaemic complications. Curr Opin Rheumatol 23: 555‐561, 2011.
 153.Hibino T, Takemura T, Sato K. Human eccrine sweat contains tissue kallikrein and kininase II. J Invest Dermatol 102: 214‐220, 1994.
 154.Hirata K, Nagasaka T, Nunomura T, Cabanac M. Local thermal sensation and finger vasoconstriction in the locally heated hand. Eur J Appl Physiol Occup Physiol 58: 92‐96, 1988.
 155.Hodges GJ, Chiu C, Kosiba WA, Zhao K, Johnson JM. The effect of microdialysis needle trauma on cutaneous vascular responses in humans. J Appl Physiol 106: 1112‐1118, 2009.
 156.Hodges GJ, Kosiba WA, Alvarez GE, Johnson JM. The role of baseline in the cutaneous vasoconstrictor responses during combined local and whole body cooling in humans. Am J Physiol Heart Circ Physiol 293: H3187‐H3192, 2007.
 157.Hodges GJ, Kosiba WA, Zhao K, Johnson JM. The involvement of norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator response to local heating in humans. J Appl Physiol 105: 233‐240, 2008.
 158.Hodges GJ, Kosiba WA, Zhao K, Johnson JM. The involvement of heating rate and vasoconstrictor nerves in the cutaneous vasodilator response to skin warming. Am J Physiol 296: H51‐H56, 2009.
 159.Hodges GJ, Zhao K, Kosiba WA, Johnson JM. The involvement of nitric oxide in the cutaneous vasoconstrictor response to local cooling in humans. J Physiol (London) 573: 849‐857, 2006.
 160.Holowatz LA, Houghton BL, Wong BJ, Wilkins BW, Harding AW, Kenney WL, Minson CT. Nitric oxide and attenuated reflex cutaneous vasodilation in aged skin. Am J Physiol 284: H1662‐H1667, 2003.
 161.Holowatz LA, Jennings JD, Lang JA, Kenney WL. Ketorolac alters blood flow during normothermia but not during hyperthermia in middle‐aged human skin. J Appl Physiol 107: 1121‐1127, 2009.
 162.Holowatz LA, Jennings JD, Lang JA, Kenney WL. Systemic low‐dose aspirin and clopidogrel independently attenuate reflex cutaneous vasodilation in middle‐aged humans. J Appl Physiol 108: 1575‐1581, 2010.
 163.Holowatz LA, Kenney WL. Local ascorbate administration augments NO‐ and non‐NO dependent reflex cutaneous vasodilation in hypertensive humans. Am J Physiol 293: H1090‐H1096, 2007.
 164.Holowatz LA, Kenney WL. Chronic low‐dose aspirin therapy attenuates reflex cutaneous vasodilation in middle‐aged humans. J Appl Physiol 106: 500‐505, 2009.
 165.Holowatz LA, Kenney WL. Peripheral mechanisms of thermoregulatory control of skin blood flow in aged humans. J Appl Physiol 109: 1538‐1544, 2010.
 166.Holowatz LA, Kenney WL. Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans. J Physiol 589: 4787‐4797, 2011a.
 167.Holowatz LA, Kenney WL. Oral atorvastatin therapy increases nitric oxide‐dependent cutaneous vasodilation in humans by decreasing ascorbate‐sensitive oxidants. Am J Physiol Regul Integr Comp Physiol 301: R763‐R768, 2011b.
 168.Holowatz LA, Santhanam L, Webb A, Berkowitz DE, Kenney WL. Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans. J Physiol 589: 2093‐2103, 2011.
 169.Holowatz LA, Thompson CS, Kenney WL. Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin. Am J Physiol Heart Circ Physiol 291: H2965‐H2970, 2006a.
 170.Holowatz LA, Thompson CS, Kenney WL. L‐Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J Physiol 574: 573‐581, 2006b.
 171.Holowatz LA, Thompson CS, Minson CT, Kenney WL. Mechanisms of acetylcholine‐mediated vasodilation in young and aged human skin. J Physiol 563: 965‐973, 2005.
 172.Holowatz LA, Thompson‐Torgerson C, Kenney WL. Aging and the control of human skin blood flow. Front Biosci 15: 718‐739, 2010.
 173.Holowatz LA, Thompson‐Torgerson CS, Kenney WL. The human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 105: 370‐372, 2008.
 174.Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30: 5‐11, 1998.
 175.Houghton BL, Holowatz LA, Minson CT. Influence of progestin bioactivity on cutaneous vascular responses to passive heating. Med Sci Sports Exerc 37: 45‐51; discussion 52, 2005.
 176.Houghton BL, Meendering JR, Wong BJ, Minson CT. Nitric oxide and noradrenaline contribute to the temperature threshold of the axon reflex response to gradual local heating in human skin. J Physiol (London) 572: 811‐820, 2007.
 177.Hökfelt TM, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M. Peptidergic neurones. Nature 284: 515‐521, 1980.
 178.Hurley HJ, Mescon H. Cholinergic innervation of the digital arteriovenous anastomoses of human skin. A histochemical localization of cholinesterase. J Appl Physiol 9: 82‐84, 1956.
 179.Hurley HJ, Mescon H, Moretti G. The anatomy and histochemistry of the arteriovenous anastomosis in human digital skin. J Invest Dermatol 27: 133‐145, 1956.
 180.Ijzerman RG, de Jongh RT, Beijk MA, van Weissenbruch MM, Delemarre‐van de Waal HA, Serné EH, Stehouwer CD. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 33: 536‐542, 2003.
 181.Ijzerman RG, Serne EH, van Weissenbruch MM, de Jongh RT, Stehouwer CD. Cigarette smoking is associated with an acute impairment of microvascular function in humans. Clin Sci (Lond) 104: 247‐252, 2003.
 182.Itoh N, Obata K, Yanaihara N, Okamoto H. Human preprovasoactive intestinal polypeptide contains a novel PHI‐27‐like peptide, PHM‐27. Nature 304: 547‐549, 1983.
 183.Jackson DN, Kenny GP. Upright LBPP application attenuates elevated postexercise resting thresholds for cutaneous vasodilation and sweating. J Appl Physiol 95: 121‐128, 2003.
 184.Jessen C, Hales JR, Molyneux GS. Hypothalamic thermosensitivity in an Emu, Dromiceius Novae‐Hollandiae. Pflugers Arch 393: 278‐280, 1982.
 185.Jeyaraj SC, Chotani MA, Mitra S, Gregg HE, Flavahan NA, Morrison KJ. Cooling evokes redistribution of α2C‐adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells. Molec Pharmacol 60: 1195‐1200, 2001.
 186.Jeyaraj SC, Unger NT, Eid AH, Mitra S, Paul El‐Dahdah N, Quilliam LA, Flavahan NA, Chotani MA. Cyclic AMP‐Rap1A signaling activates RhoA to induce α(2c)‐adrenoceptor translocation to the cell surface of microvascular smooth muscle cells. Am J Physiol Cell Physiol 303: C499‐C511, 2012.
 187.Johansson O. Evidence for PHI‐immunoreactive nerve fibers in the human skin: Coexistence with VIP? Medical Biology 64: 67‐73, 1986.
 188.Johnson JM. Nonthermoregulatory control of human skin blood flow. J Appl Physiol 61: 1613‐1622, 1986.
 189.Johnson JM. Central and peripheral adjustments to long‐term exercise in humans. Can J Sport Sci 12:, 1987.
 190.Johnson JM. The cutaneous circulation. In: Shepherd AP, Öberg P, editors. Laser Doppler Blood Flowmetry. Boston: Kluwer Academic Publishers, 1990.
 191.Johnson JM. Exercise and the cutaneous circulation. Exercise Sports Sci Rev 20: 59‐97, 1992.
 192.Johnson JM, Proppe DW. Cardiovascular adjustments to heat stress. In: Fregly MJ, Blatteis CM, editors. Handbook of Physiology‐Environmental Physiology. New York: Oxford University Press, 1996.
 193.Johnson JM, Brengelmann GL, Hales JRS, Vanhoutte PM, Wenger CB. Regulation of the cutaneous circulation. Fed Proc 45: 2841‐2850, 1986.
 194.Johnson JM, Brengelmann GL, Rowell LB. Interactions between local and reflex influences on human forearm skin blood flow. J Appl Physiol 41: 826‐831, 1976.
 195.Johnson JM, Kellogg DL. Thermoregulatory and thermal control in the human cutaneous circulation. Front Biosci (Schol Ed) 2: 825‐853, 2010.
 196.Johnson JM, Niederberger M, Rowell LB, Eisman MM, Brengelmann GL. Competition between cutaneous vasodilator and vasoconstrictor reflexes in man. J Appl Physiol 35: 798‐803, 1973.
 197.Johnson JM, O'Leary DS, Taylor WF, Kosiba W. Effect of local warming on forearm reactive hyperaemia. Clin Physiol 6: 337‐346, 1986.
 198.Johnson JM, Park MK. Reflex control of skin blood flow by skin temperature: Role of core temperature. J Appl Physiol 47: 1188‐1193, 1979.
 199.Johnson JM, Park MK. Effect of upright exercise on threshold for cutaneous vasodilation and sweating. J Appl Physiol 50: 814‐818, 1981.
 200.Johnson JM, Park MK. Effect of heat stress on cutaneous vascular responses to the initiation of exercise. J Appl Physiol 53: 744‐749, 1982.
 201.Johnson JM, Pérgola PE, Liao FK, Kellogg DL, Jr, Crandall CG. Skin of the dorsal aspect of human hands and fingers possesses an active vasodilator system. J Appl Physiol 78: 948‐954, 1995).
 202.Johnson JM, Rowell LB. Forearm skin and muscle vascular responses to prolonged leg exercise in man. J Appl Physiol 39: 916‐924, 1975.
 203.Johnson JM, Rowell LB, Niederberger M, Eisman MM. Human splanchnic and forearm vasoconstrictor responses to reductions of right atrial and aortic pressures. Circ Res 34: 515‐524, 1974.
 204.Johnson JM, Taylor WF, Shepherd AP, Park MK. Laser‐Doppler measurement of skin blood flow: Comparison with plethysmography. J Appl Physiol 56: 798‐803, 1984.
 205.Johnson JM, Yen TC, Zhao K, Kosiba WA. Sympathetic, sensory, and nonneural contributions to the cutaneous vasoconstrictor response to local cooling. Am J Physiol Heart Circ Physiol 288: 1573‐1579, 2005.
 206.Jose AD, Stitt F, Collison D. The effects of exercise and changes in body temperature on the intrinsic heart rate in man. Am Heart J 79: 488‐498, 1970.
 207.Journeay WS, Carter R, Kenny GP. Thermoregulatory control following dynamic exercise. Aviat Space Environ Med 77: 1174‐1182, 2006.
 208.Kahan T, Pernow J, Schwieler J, Lundberg JM, Hjemdahl P, Wallin BG. Involvement of neuropeptide Y in sympathetic vascular control of skeletal muscle in vivo. J Hypertens Suppl 6: S532‐S534, 1988.
 209.Kahan T, Taddei S, Pedernelli R, Hjelmdhal P, Salvetti A. Non‐adrenergic sympathetic vascular control of the human forearm in hypertension: Possible involvement of neuropeptide Y. J Cardiovasc Pharmacol 19: 587‐592, 1992.
 210.Kamijo Y‐I, Lee K, Mack GW. Active cutaneous vasodilation in resting humans during mild heat stress. J Appl Physiol 98: 829‐837, 2005.
 211.Kamon E, Belding HS. Dermal blood flow in the resting arm during leg exercise. J Appl Physiol 26: 317‐320, 1969.
 212.Keller DM, Davis SL, Low DA, Shibasaki M, Raven PB, Crandall CG. Carotid baroreceptor stimulation alters cutaneous vascular conductance during whole‐body heating in humans. J Physiol 577: 925‐933, 2006.
 213.Keller DM, Sander M, Stallknecht B, Crandall CG. α‐Adrenergic vasoconstrictor responsiveness is preserved in the heated human leg. J Physiol 588: 3799‐3808, 2010.
 214.Kellogg DL Jr. in vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 100: 1709‐1718, 2006a.
 215.Kellogg DL Jr. in vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans. J Appl Physiol 100: 1709‐1718, 2006b.
 216.Kellogg DL Jr, Crandall CG, Liu Y, Charkoudian N, Johnson JM. Nitric oxide and cutaneous active vasodilation during heat stress in humans. J Appl Physiol 85: 824‐829, 1998.
 217.Kellogg DL Jr, Hodges GJ, Orozco CR, Phillips TM, Zhao JL, Johnson JM. Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis. J Appl Physiol 103: 963‐968, 2007.
 218.Kellogg DL Jr, Johnson JM, Kenney WL, Pérgola PE, Kosiba WA. Mechanisms of control of skin blood flow during prolonged exercise in humans. Am J Physiol 265: H562‐H568, 1993.
 219.Kellogg DL Jr, Johnson JM, Kosiba WA. Selective abolition of adrenergic vasoconstrictor responses in skin by local iontophoresis of bretylium. Am J Physiol 257: H1599‐H1606, 1989.
 220.Kellogg DL Jr, Johnson JM, Kosiba WA. Baroreflex control of the cutaneous active vasodilator system in humans. Circ Res 66: 1420‐1426, 1990.
 221.Kellogg DL Jr, Johnson JM, Kosiba WA. Competition between the cutaneous active vasoconstrictor and vasodilator systems during exercise in man. Am J Physiol 261: H1184‐H1189, 1991a.
 222.Kellogg DL Jr, Johnson JM, Kosiba WA. Control of internal temperature threshold for active cutaneous vasodilation by dynamic exercise. J Appl Physiol 71: 2476‐2482, 1991b.
 223.Kellogg DL Jr, Liu Y, Kosiba IF, O'Donnell D. Role of Nitric Oxide in the Vascular Effects of Local Warming of the Skin in Humans. J Appl Physiol 86: 1185‐1190, 1999.
 224.Kellogg DL Jr, Liu Y, McAllister K, Friel C, Pérgola PE. Bradykinin does not mediate cutaneous active vasodilation during heat stress in humans. J Appl Physiol 93: 1215‐1221, 2002.
 225.Kellogg DL Jr, Liu Y, Pérgola PE. Gender differences in the endothelin‐B receptor contribution to basal vascular tone in humans. J Appl Physiol 91: 2407‐2411, 2001.
 226.Kellogg DL Jr, Morris SR, Rodriguez SB, Liu Y, Grossmann M, Stagni G, Shepherd AMM. Thermoregulatory reflexes and cutaneous active vasodilation during heat stress in hypertensive humans. J Appl Physiol 85: 175‐180, 1998.
 227.Kellogg DL Jr, Pérgola PE, Kosiba WA, Grossmann M, Johnson JM. Cutaneous active vasodilation in humans is mediated by cholinergic nerve co‐transmission. Circ Res 77: 1222‐1228, 1995.
 228.Kellogg DL Jr, Zhao J, Wu Y. Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress. J Appl Physiol 107: 1438‐1444, 2009.
 229.Kellogg DL Jr, Zhao JL, Friel C, Roman LJ. Nitric oxide concentration increases in the cutaneous interstitial space during heat stress in humans. J Appl Physiol 94: 1971‐1977, 2003.
 230.Kellogg DL Jr, Zhao JL, Wu Y. Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. Am J Physiol Heart Circ Physiol 295: H123‐H129, 2008a.
 231.Kellogg DL Jr, Zhao JL, Wu Y. Neuronal Nitric Oxide Synthase Mechanisms in the Cutaneous Vasculature of Humans in vivo. J Physiol (London) 586: 847‐857, 2008b.
 232.Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans. J Appl Physiol 109: 95‐100, 2010.
 233.Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans. J Appl Physiol 110: 1406‐1413, 2011.
 234.Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Nitric oxide and receptors for VIP and PACAP in cutaneous active vasodilation during heat stress in humans. J Appl Physiol 113: 1512‐1518, 2012.
 235.Kenney WL, Kamon E. Comparative physiological responses of normotensive and essentially hypertensove men to exercise in the heat. Eur J Appl Physiol 52: 196‐201, 1984.
 236.Kenney WL, Kamon E, Buskirk ER. Effect of mild essential hypertension on control of forearm blood flow during exercise in the heat. J Appl Physiol 56: 930‐935, 1984.
 237.Kenney WL, Tankersley CG, Newswanger DL, Hyde DE, Puhl SM, Turner NL. Age and hypohydration independently influence the peripheral vascular response to heat stress. J Appl Physiol 68: 1902‐1908, 1990.
 238.Kenny GP, Chen AA, Nurbakhsh BA, Denis PM, Proulx CE, Giesbrecht GG. Moderate exercise increases postexercise thresholds for vasoconstriction and shivering. J Appl Physiol 85: 1357‐1361, 1998.
 239.Kenny GP, Périard J, Journeay WS, Sigal RJ, Reardon FD. Cutaneous active vasodilation in humans during passive heating postexercise. J Appl Physiol 95: 1025‐1031, 2003.
 240.Khan F, Elhadd TA, Greene SA, Belch JJ. Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care 23: 215‐220, 2000.
 241.Khan F, Patterson D, Belch JJ, Hirata K, Lang CC. Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci (Lond) 115: 295‐300, 2008.
 242.Klede M, Clough G, Lischetzki G, Schmelz M. The effect of the nitric oxide synthase inhibitor N‐nitro‐L‐arginine‐methyl ester on neuropeptide‐induced vasodilation and protein extravasation in human skin. J Vasc Res 40: 105‐114, 2003.
 243.Kolka MA, Stephenson LA. Cutaneous blood flow and local sweating after systemic atropine administration. Pfluegers Archiv 410: 524‐529, 1987.
 244.Kolka MA, Stephenson LA. Atropine‐induced cutaneous vasodilation decreases esophageal temperature during exercise. Am J Physiol 257: R1089‐R1095, 1989.
 245.Koroxenidis GT, Shepherd JT, Marshall RJ. Cardiovascular response to acute heat stress. J Appl Physiol 16: 869‐872, 1961.
 246.Kraemer‐Aguiar LG, Laflor CM, Bouskela E. Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndrome. Metabolism 57: 1740‐1746, 2008.
 247.Krajnak K, Dong RG, Flavahan S, Welcome D, Flavahan NA. Acute vibration increases α2c‐adrenergic smooth muscle constriction and alters thermosensitiivty of cutaneous arteries. J Appl Physiol 100: 1230‐1237, 2006.
 248.Kruger A, Stewart J, Sahityani R, O'Riordan E, Thompson C, Adler S, Garrick R, Vallance P, Goligorsky MS. Laser Doppler flowmetry detection of endothelial dysfunction in end‐stage renal disease patients: Correlation with cardiovascular risk. Kidney Int 70: 157‐164, 2006.
 249.Lang JA, Holowatz LA, Kenney WL. Local tetrahydrobiopterin administration augments cutaneous vasoconstriction in aged humans. J Physiol 587: 3967‐3974, 2009.
 250.Lang JA, Holowatz LA, Kenney WL. Localized tyrosine or tetrahydrobiopterin supplementation corrects the age‐related decline in cutaneous vasoconstriction. J Physiol 588: 1361‐1368, 2010.
 251.Lang JA, Jennings JD, Holowatz LA, Kenney WL. Reflex vasoconstriction in aged human skin increasingly relies on Rho kinase‐dependent mechanisms during whole body cooling. Am J Physiol Heart Circ Physiol 297: H1792‐H1797, 2009.
 252.Larkin SW, Williams TJ. Evidence for sensory nerve involvement in cutaneous reactive hyperemia in humans. Circ Res 73: 147‐154, 1993.
 253.Leslie SJ, Rahman MQ, Denvir MA, Newby DE, Webb DJ. Endothelins and their inhibition in the human skin microcirculation: ET[1‐31], a new vasoconstrictor peptide. Br J Clin Pharmacol 57: 720‐725, 2004.
 254.Lewis T. The Blood Vessels of the Human Skin and Their Responses. Shaw & Sons, 1927.
 255.Lewis T. Observations upon the reactions of the vessels of the human skin to cold. Heart 15: 177‐208, 1930.
 256.Lewis T, Grant R. Observations upon reactive hyperaemia in man. Heart 12: 73, 1925.
 257.Lewis T, Pickering GW. Vasodilation in the limbs in response to warming the body; with evidence for sympathetic vasodilator nerves in man. Heart 16: 33‐51, 1931.
 258.Lind AR, Leithead CS, McNicol GW. Cardiovascular changes during syncope induced by tilting men in the heat. J Appl Physiol 25: 268‐276, 1968.
 259.Lindblad LE, Ekenvall L. Alpha‐adrenoreceptors in the vessels of human finger skin. Acta Physiol Scand 128: 219‐222, 1986.
 260.Lindblad LE, Ekenvall L, Ancker K, Rohman H, Oberg PA. Laser Doppler flow‐meter assessment of iontophoretically applied norepinephrine on human. J Invest Dermatol 87: 634‐636, 1986.
 261.Lindblad LE, Ekenvall L, Klingstedt C. Neural regulation of vascular tone and cold induced vasoconstriction in human finger skin. J Autonom Nerv Sys 30: 169‐174, 1990.
 262.Lorenzo S, Halliwill JR, Sawka MN, Minson CT. Heat acclimation improves exercise performance. J Appl Physiol 109: 1140‐1147, 2010.
 263.Lorenzo S, Minson CT. Human cutaneous reactive hyperaemia: Role of BKCa channels and sensory nerves. J Physiol 585: 295‐303, 2007.
 264.Lorenzo S, Minson CT. Heat acclimation improves cutaneous vascular function and sweating in trained cyclists. J Appl Physiol 109: 1736‐1743, 2010.
 265.Lossius K, Eriksen M, Walløe L. Fluctuations in blood flow to acral skin in humans: Connection with heart rate and blood pressure variability. J Physiol 460: 641‐655, 1993.
 266.Love AHG, Shanks RG. The relationship between the onset of sweating and vasodilation in the forearm during body heating. J Physiol (London) 162: 121‐128, 1962.
 267.Lundberg J. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) in neurons of cat exocrine glands. Acta Physiol Scand 112(Suppl. 496): 1‐57, 1981.
 268.Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48: 113‐178, 1996.
 269.Lundberg JM, Anggard A, Fahrenkrug J, Hokfelt T, Mutt V. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: Functional significance of co‐existing transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A 77: 1651‐1655, 1980.
 270.Lundberg JM, Anggard A, Fahrenkrug J, Lundgren C, Homstedt B. Co‐release of VIP and acetylcholine in relation to blood flow and salivary secretion in cat submandibular salivary gland. Acta Physiol Scand 115: 525‐528, 1982.
 271.Lundberg JM, Ånggård A, Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for submandibular gland blood flow and secretion. Acta Physiol Scand 113: 329‐336, 1981.
 272.Lundberg JM, Franco‐Cerecda A, Lou Y, Modin A, and Pernow J. Differential Release of Classical Transmitters and Peptides. In: Stjårne L, Greengard P, Grillner S, Hokfelt T, Ottoson D, editors. Molecular and Cellular Mechanisms of Neurotransmitter Release. New York: Raven Press, Ltd., 1994.
 273.Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B. Neuropeptide Y and sympathetic vascular control in man. Regul Pept 13: 41‐52, 1985.
 274.Lundeberg L, Nordlind K. Vasoactive intestinal polypeptide in allergic contact dermatitis: An immunohistochemical and radioimmunoassay study. Arch Dermatol Res 291: 201‐206, 1999.
 275.MacDermot HE. The responses of the blood vessels of the human skin. Br Med J 2: 309‐310, 1927.
 276.Magerl W, Treede RD. Heat‐evoked vasodilatation in human hairy skin: Axon reflexes due to low‐level activity of nociceptive afferents. J Physiol (London) 497: 837‐848, 1996.
 277.Mandadi S, Sokabe T, Shibasaki K, Katanosaka K, Mizuno A, Moqrich A, Patapoutian A, Fukumi‐Tominaga T, Mizumura K, Tominaga M. TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Arch 458: 1093‐1102, 2009.
 278.Martin HL, Loomis JL, Kenney WL. Maximal skin vascular conductance in subjects aged 5‐85 yr. J Appl Physiol 79: 297‐301, 1995.
 279.McCord GR, Cracowski JL, Minson CT. Prostanoids contribute to cutaneous active vasodilation in humans. Am J Physiol Regulatory Integrative Comp Physiol 291: R596‐R602, 2005.
 280.McInnis NH, Journeay WS, Jay O, Leclair E, Kenny GP. 15 degrees head‐down tilt attenuates the postexercise reduction in cutaneous vascular conductance and sweating and decreases esophageal temperature recovery time. J Appl Physiol 101: 840‐847, 2006.
 281.Medow MS, Bamji N, Clarke D, Ocon AJ, Stewart JM. Reactive oxygen species (ROS) from NADPH and xanthine oxidase modulate the cutaneous local heating response in healthy humans. J Appl Physiol 111: 20‐26, 2011.
 282.Medow MS, Minson CT, Stewart JM. Decreased microvascular nitric oxide‐dependent vasodilation in postural tachycardia syndrome. Circulation 112: 2611‐2618, 2005.
 283.Medow MS, Taneja I, Stewart JM. Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans. Am J Physiol Heart Circ Physiol 293: H425‐H432, 2007.
 284.Milner P, Bodin P, Guiducci S, Del Rosso A, Kahaleh MB, Matucci‐Cerinic M, Burnstock G. Regulation of substance P mRNA expression in human dermal microvascular endothelial cells. Clin Exp Rheumatol 22: S24‐S27, 2004.
 285.Minson CT. Thermal provocation to evaluate microvascular reactivity in human skin. J Appl Physiol 109: 1239‐1246, 2010.
 286.Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91: 1619‐1626, 2001.
 287.Minson CT, Halliwill JR, Young TM, Joyner MJ. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation 102: 1473‐1476, 2000.
 288.Minson CT, Holowatz LA, Wong BJ, Kenney WL, Wilkins BW. Decreased nitric oxide‐ and axon reflex‐mediated cutaneous vasodilation with age during local heating. J Appl Physiol 93: 1644‐1649, 2002.
 289.Minson CT, Wladkowski SL, Cardell AF, Pawelczyk JA, Kenney WL. Age alters the cardiovascular response to direct passive heating. J Appl Physiol 84: 1323‐1332, 1998.
 290.Mitchell JH, Smith SA. Unravelling the mysteries of the exercise pressor reflex at the cellular level. J Physiol 586: 3025‐3026, 2008.
 291.Mitono H, Endoh H, Okazaki K, Ichinose T, Masuki S, Takamata A, Nose H. Acute hypoosmolality attenuates the suppression of cutaneous vasodilation with increased exercise intensity. J Appl Physiol 99: 902‐908, 2005.
 292.Montagna W, Yun J, Formisano V. Histology and cytochemistry of human skin. Cholinesterase‐containing nerves in face. Arch Dermatol 90: 526‐529, 1964.
 293.Munce TA, Kenney WL. Age‐specific modification of local cutaneous vasodilation by capsaicin‐sensitive primary afferents. J Appl Physiol 95: 1016‐1024, 2003.
 294.Murphy MN, Mizuno M, Mitchell JH, Smith SA. Cardiovascular regulation by skeletal muscle reflexes in health and disease. Am J Physiol Heart Circ Physiol 301: H1191‐H1204, 2011.
 295.Münzel T, Gori T, Bruno RM, Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31: 2741‐2748, 2010.
 296.Nagasaka T, Hirata K, Mano T, Iwase S, Rossetti Y. Heat‐induced finger vasoconstriction controlled by skin sympathetic nerve activity. J Appl Physiol 68: 71‐75, 1990.
 297.Nagasaka T, Hirata K, Nunomura T. Contribution of arteriovenous anastomoses to vasoconstriction induced by local heating of the human finger. Jpn J Physiol 37: 425‐433, 1987.
 298.Nielsen M, Herrington LP, Winslow C‐E. The effect of posture upon peripheral circulation. Am J Physiol 127: 573‐580, 1939.
 299.Nilsson GE, Tenland T, Oberg PA. Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 27: 597‐604, 1980.
 300.Nolano M, Provitera V, Caporaso G, Stancanelli A, Leandri M, Biasiotta A, Cruccu G, Santoro L, Truini A. Cutaneous innervation of the human face as assessed by skin biopsy. J Anat 222: 161‐169, 2013.
 301.Nolano M, Provitera V, Perretti A, Stancanelli A, Saltalamacchia AM, Donadio V, Manganelli F, Lanzillo B, Santoro L. Ross syndrome: A rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects. Brain 129: 2119‐2131, 2006.
 302.Odum L, Petersen LJ, Skov PS, Ebskov LB. Pituitary adenylate cyclase activation peptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells. Inflamm Res 47: 488‐492, 1998.
 303.Öberg P. Laser‐Doppler flowmetry. Critical Rev Biomed Eng 18: 125‐163, 1990.
 304.Padilla SL, Garcia‐Villalon AL, Monge L, Garcia JL, Fernandez N, Gomez B, Dieguez G. Peptidergic modulation of the sympathetic contraction in the rabbit ear: Effects of temperature. Br J Pharmacol 121: 21‐28, 1997.
 305.Peier AM, Reeve AJ, Andersson DA, Moqrich A, Earley TJ, Hergarden AC, Story GM, Colley S, Hogenesch JB, McIntyre P, Bevan S, Patapoutian A. A heat‐sensitive TRP channel expressed in keratinocytes. Science 296: 2046‐2049, 2002.
 306.Petrofsky J, Paluso D, Anderson D, Swan K, Alshammari F, Katrak V, Murugesan V, Hudlikar AN, Chindam T, Trivedi M, Lee H, Goraksh N, Yim JE. The ability of different areas of the skin to absorb heat from a locally applied heat source: The impact of diabetes. Diabetes Technol Ther 13: 365‐372, 2011.
 307.Petrofsky JS, McLellan K, Bains GS, Prowse M, Ethiraju G, Lee S, Gunda S, Lohman E, Schwab E. Skin heat dissipation: The influence of diabetes, skin thickness, and subcutaneous fat thickness. Diabetes Technol Ther 10: 487‐493, 2008.
 308.Pérgola PE, Johnson JM, Kellogg DL, Jr, Kosiba WA. Control of skin blood flow by whole body and local skin cooling in exercising humans. Am J Physiol 270: H208‐H215, 1996.
 309.Pérgola PE, Kellogg DL, Jr, Johnson JM, Kosiba WA. Reflex control of active cutaneous vasodilation by skin temperature in humans. Am J Physiol 266: H1979‐H1984, 1994.
 310.Pérgola PE, Kellogg DL, Jr, Johnson JM, Kosiba WA, Solomon DE. Role of sympathetic nerves in the vascular effects of local temperature in human forearm skin. Am J Physiol 265: H785‐H792, 1993.
 311.Pierzga JM, Frymoyer A, Kenney WL. Delayed distribution of active vasodilation and altered vascular conductance in aged skin. J Appl Physiol 94: 1045‐1053, 2003.
 312.Racchi H, Irarrazabal MJ, Howard M, Moran S, Zalaquett R, Huidobro‐Toro JP. Adenosine 5'‐triphosphate and neuropeptide Y are co‐transmitters in conjunction with noradrenaline in the human cutaneous vein. Br J Pharmacol 1226: 1175‐1185, 1999.
 313.Radigan LR, Robinson S. Effects of environmental heat stress and exercise on renal blood flow and filtration rate. J Appl Physiol 2: 185‐191, 1949.
 314.Rambotti MG, Simonetti S, Spreca A. PACAP activated adenylate cyclase in human sweat glands. An ultracytochemical study. Eur J Histochem 46: 223‐228, 2002.
 315.Richardson D. Effects of age on cutaneous circulatory response to direct heat on the forearm. J Gerontol 44: M189‐M194, 1989.
 316.Roddie IC. Circulation to skin and adipose tissue. In: Shepherd JT, Abboud FM, editors. Handbook of Physiology: The Cardiovascular System. Bethesda, MD: Am. Physiol. Soc., 1983.
 317.Roddie IC. Sympathetic vasodilation in human skin. J Physiol 548: 336‐337, 2003.
 318.Roddie IC, Shepherd JT. The effects of carotid artery compression in man with special reference to changes in vascular resistance in the limbs. J Physiol 139: 377‐384, 1957.
 319.Roddie IC, Shepherd JT. Nervous control of the circulation in skeletal muscle. Br Med Bull 19: 115‐119, 1963.
 320.Roddie IC, Shepherd JT, Whelan RF. The contribution of constrictor and dilator nerves to the skin vasodilation during body heating. J Physiol (London) 136: 489‐497, 1957.
 321.Roddie IC, Shepherd JT, Whelan RF. Reflex changes in vasoconstrictor tone in human skeletal muscle in response to stimulation of receptors in a low‐pressure area of the intrathoracic vascular bed. J Physiol 139: 369‐376, 1957.
 322.Roddie IC, Shepherd JT, Whelan RF. The vasomotor nerve supply of the human forearm. Clin Sci 16: 67‐74, 1957.
 323.Roddie IC, Shepherd JT, Whelan RF. Reflex changes in human skeletal muscle blood flow associated with intrathoracic pressure changes. Circ Res 6: 232‐238, 1958.
 324.Romero MJ, Platt DH, Tawfik HE, Labazi M, El‐Remessy AB, Bartoli M, Caldwell RB, Caldwell RW. Diabetes‐induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102: 95‐102, 2008.
 325.Rooke GA, Savage MV, Brengelmann GL. Maximal skin blood flow is decreased in elderly men. J Appl Physiol 77: 11‐14, 1994.
 326.Roosterman D, George T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of Skin Function: The Skin as a Neuroendocrine Organ. Physiol Rev 86: 1309‐1379, 2006.
 327.Roustit M, Cracowski JL. Non‐invasive assessment of skin microvascular function in humans: An insight into methods. Microcirculation 19: 47‐64, 2012.
 328.Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiol Rev 54: 75‐159, 1974.
 329.Rowell LB. Cardiovascular adjustments to thermal stress. In: Shepherd JT, Abboud FM, editors. Handbook of Physiology: The Cardiovascular System. Bethesda, MD: Am. Physiol. Soc., 1983a.
 330.Rowell LB. Cardiovascular aspects of human thermoregulation. Circ Res 52: 367‐379, 1983b.
 331.Rowell LB, Brengelmann GL, Blackmon JR, Murray JA. Redistribution of blood flow during sustained high skin temperature in resting man. J Appl Physiol 28: 415‐420, 1970.
 332.Rowell LB, O'Leary DS. Reflex control of the circulation during exercise: Chemoreflexes and mechanoreflexes. J Appl Physiol 69: 407‐418, 1990.
 333.Rowell LB, O'Leary DS, Kellogg DL. Integration of cardiovascular control systems in dynamic exercise. In: Rowell LB, Shepherd JT, editors. Handbook of Physiology, Exercise: Regulation and Integration of Multiple Systems. American Physiological Society, 1996.
 334.Rowell LB, Wyss CR, Brengelmann GL. Sustained human skin and muscle vasoconstriction with reduced baroreceptor activity. J Appl Physiol 34: 639‐643, 1973.
 335.Saad AR, Stephens DP, Bennett LA, Charkoudian N, Kosiba WA, Johnson JM. Influence of isometric exercise on blood flow and sweating in glabrous and nonglabrous human skin. J Appl Physiol 91: 2487‐2492, 2001.
 336.Saito M, Maito M, Mano T. Different responses in skin and muscle sympathetic nerve activity to static muscle contraction. J Appl Physiol 69: 2085‐2090, 1990.
 337.Salerud EG, Nilsson GE. Integrating probe for tissue laser Doppler flowmeters. Med Biol Eng Comput 24: 415‐419, 1986.
 338.Sandeman DD, Pym CA, Green EM, Seamark C, Shore AC, Tooke JE. Microvascular vasodilatation in feet of newly diagnosed non‐insulin dependent diabetic patients. BMJ 302: 1122‐1123, 1991.
 339.Saumet JL, Dittmar A, Leftheriotis G. Non‐invasive measurement of skin blood flow: Comparison between plethysmography, laser‐Doppler flowmeter and heat thermal clearance method. Int J Microcirc Clin Exp 5: 73, 1986.
 340.Saumet JL, Kellogg DL, Jr, Taylor WF, Johnson JM. Cutaneous laser‐Doppler flowmetry: Influence of underlying muscle blood flow. J Appl Physiol 65: 478‐481, 1988.
 341.Savage MV, Brengelmann GL. Control of skin blood flow in the neutral zone of human body temperature regulation. J Appl Physiol 80: 1249‐1257, 1996.
 342.Savage MV, Brengelmann GL, Buchan AMJ, Freund PR. Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation. J Appl Physiol 69: 2149‐2154, 1990.
 343.Sawka MN, Wenger CB, and Pandolf KB. Thermoregulatory responses to acute exercise‐heat stress and heat acclimation. In: Fregly MJ, Blatteis CM, editors. Handbook of Physiology Section 4: Environmental Physiology. New York: Oxford University Press, 1996.
 344.Sawmiller DR, Ashtari M, Urueta H, Leschinsky M, Henning RJ. Mechanisms of vasoactive intestinal peptide‐elicited coronary vasodilation in the isolated perfused rat heart. Neuropeptides 40: 349‐355, 2006.
 345.Schmelz M, Luz O, Averbeck B, Bickel A. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis. Neurosci Lett 230: 117‐120, 1997.
 346.Schmidt‐Nielsen K, Dawson T, Hammel H, Hinds D, Jackson D. The jack rabbit‐a study in its desert survival. Hvalradets Skr 48: 125‐142, 1956.
 347.Settergren M, Pernow J, Brismar K, Jörneskog G, Kalani M. Endothelin‐A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy. J Vasc Res 45: 295‐302, 2008.
 348.Shastry S, Joyner MJ. Geldanamycin attenuates NO‐mediated dilation in human skin. Am J Physiol Heart Circ Physiol 282: H232‐H236, 2002.
 349.Shastry S, Minson CT, Wilson SA, Dietz NK, Joyner MJ. Effects of atropine and L‐NAME on cutaneous blood flow during body heating in humans. J Appl Physiol 88: 467‐472, 2000.
 350.Shastry S, Reed AS, Halliwill JR, Dietz NM, Joyner MJ. Effects of nitric oxide synthase inhibition on cutaneous vasodilation during body heating in humans. J Appl Physiol 85: 830‐834, 1998.
 351.Shepherd JT. Physiology of the Circulation in Human Limbs in Health and Disease. Philadelphia: Saunders, 1963, p. 149.
 352.Sherman JR. Normal arteriovenous anastomoses. Medicine 42: 247‐268, 1963.
 353.Shibasaki M, Aoki K, Morimoto K, Johnson JM, Takamata A. Plasma hyperosmolality elevates the internal temperature threshold for active thermoregulatory vasodilation during heat stress in humans. Am J Physiol Regul Integr Comp Physiol 297: R1706‐R1712, 2009.
 354.Shibasaki M, Davis SL, Cui J, Low DA, Keller DM, Durand S, Crandall CG. Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat‐stressed human. J Physiol (London) 575: 953‐959, 2006.
 355.Shibasaki M, Durand S, Davis SL, Cui J, Low DA, Keller DM, Crandall CG. Endogenous nitric oxide attenuates neutrally mediated cutaneous vasoconstriction. J Physiol (London) 585: 627‐634, 2007.
 356.Shibasaki M, Wilson TE, Cui J, Crandall CG. Acetylcholine released from cholinergic nerves contributes to cutaneous vasodilation during heat stress. J Appl Physiol 93: 1947‐1951, 2002.
 357.Shore AC, Price KJ, Sandeman DD, Green EM, Tripp JH, Tooke JE. Impaired microvascular hyperaemic response in children with diabetes mellitus. Diabet Med 8: 619‐623, 1991.
 358.Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33: 155‐188, 1981.
 359.Skagen K, Bonde‐Petersen F, Henriksen O. Evidence that the arterial baroreceptors influence muscle blood flow and not subcutaneous flow in man. Acta Physiol Scand 123: 405‐409, 1985.
 360.Skagen K, Henriksen O, Bonde‐Petersen F. Effect of lower body negative pressure upon local regulation of blood flow in human subcutaneous tissue. Acta Physiol Scand 111: 113‐120, 1981.
 361.Smith CJ, Santhanam L, Bruning RS, Stanhewicz A, Berkowitz DE, Holowatz LA. Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension 58: 935‐942, 2011.
 362.Sokolnicki LA, Roberts SK, Wilkins BW, Basu A, Charkoudian N. Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus. Am J Physiol Heart Endocrinol Metab 292: E314‐E318, 2007.
 363.Sokolnicki LA, Strom NA, Roberts SK, Kingsley‐Berg SA, Basu A, Charkoudian N. Skin blood flow and nitric oxide during body heating in type 2 diabetes mellitus. J Appl Physiol 106: 566‐570, 2009.
 364.Stachenfeld NS. Sex hormone effects on body fluid regulation. Exerc Sport Sci Rev 36: 152‐159, 2008.
 365.Stachenfeld NS, Silva C, Keefe DL. Estrogen modifies the temperature effects of progesterone. J Appl Physiol 88: 1643‐1649, 2000.
 366.Stanhewicz AE, Bruning RS, Smith CJ, Kenney WL, Holowatz LA. Local tetrahydrobiopterin administration augments reflex cutaneous vasodilation through nitric oxide‐dependent mechanisms in aged human skin. J Appl Physiol 112: 791‐797, 2012.
 367.Steinhoff M, McGregor GP, Radleff‐Schlimme A, Steinhoff A, Jarry H, Schmidt WE. Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: Expression of PACAP‐38 is increased in patients with psoriasis. Regul Pept 80: 49‐55, 1999.
 368.Stephens DP, Aoki K, Kosiba WA, Johnson JM. Nonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men. Am J Physiol Heart Circ Physiol 280: H1496‐H1504, 2001.
 369.Stephens DP, Bennett LA, Aoki K, Kosiba WA, Charkoudian N, Johnson JM. Sympathetic nonnoradrenergic cutaneous vasoconstriction in women is associated with reproductive hormone status. Am J Physiol Heart Circ Physiol 282: H264‐H272, 2002.
 370.Stephens DP, Charkoudian N, Benevento JM, Johnson JM, Saumet JL. The influence of topical capsaicin on the local thermal control of skin blood flow in humans. Am J Physiol Regul Integr Comp Physiol 281: R894‐R901, 2001.
 371.Stephens DP, Saad A, Bennett LA, Kosiba WA, Johnson JM. Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans. Am J Physiol Heart Circ Physiol 287: H1401‐H1409, 2004.
 372.Stephenson LA, Kolka MA. Thermoregulation in women. Exercise Sports Sci Rev 21: 231‐262, 1993.
 373.Stern MD, Lappe DL, Bowen PD, Chimosky JE, Holloway GA, Keiser HR, Bowman RL. Contiuous measurement of tissue blood flow by laser‐Doppler spectroscopy. Am J Physiol Heart Circ Physiol 232: H441‐H448, 1977.
 374.Stewart J, Kohen A, Brouder D, Rahim F, Adler S, Garrick R, Goligorsky MS. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am J Physiol Heart Circ Physiol 287: H2687‐H2696, 2004.
 375.Stewart JM, Medow MS, Minson CT, Taneja I. Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 293: H2161‐H2167, 2007.
 376.Stewart JM, Medow MS, Minson CT, Taneja I. Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 293: H2161‐H2167, 2007.
 377.Stewart JM, Ocon AJ, Medow MS. Ascorbate improves circulation in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 301: H1033‐H1042, 2011.
 378.Stewart JM, Taneja I, Raghunath N, Clarke D, Medow MS. Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response. Am J Physiol Heart Circ Physiol 295: H327‐H334, 2008.
 379.Strom NA, Sawyer JR, Roberts SK, Kinsley‐Berg SM, Charkoudian N. Local sensory nerve control of skin blood flow during local warming in type 2 diabetes mellitus. J Appl Physiol 108: 293‐297, 2010.
 380.Stulc T, Kasalová Z, Prázný M, Vrablík M, Skrha J, Ceska R. Microvascular reactivity in patients with hypercholesterolemia: Effect of lipid lowering treatment. Physiol Res 52: 439‐445, 2003.
 381.Sugenoya J, Iwase S, Mano T, Sugiyama Y, Ogawa T, Nishiyama T, Nishimura N, Kimura T. Vasodilator component in sympathetic nerve activity destined for the skin of the dorsal foot of mildly heated humans. J Physiol 507: 603‐610, 1998.
 382.Sugenoya J, Ogawa T, Jmai K, Ohnishi N, Natsume T. Cutaneous vasodilation responses synchronize with sweat expulsions. Eur J Appl Physiol 71: 33‐40, 1995.
 383.Sulli A, Soldano S, Pizzorni C, Montagna P, Secchi ME, Villaggio B, Seriolo B, Brizzolara R, Cutolo M. Raynaud's phenomenon and plasma endothelin: Correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 36: 1235‐1239, 2009.
 384.Summers MA, O'Dorisio MS, Cox MO, Lara‐Marquez M, Goetzl EJ. A lymphocyte‐generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects. J Pharmacol Exp Ther 306: 638‐645, 2003.
 385.Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662‐680, 2007.
 386.Tabata H, Yamakage A, Yamazaki S. Cutaneous localization of endothelin‐1 in patients with systemic sclerosis: Immunoelectron microscopic study. Int J Dermatol 36: 272‐275, 1997.
 387.Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications. Rev Endocr Metab Disord 11: 61‐74, 2010.
 388.Taddei S, Pedrinelli R, Salvetti A. Sympathetic nervous system‐dependent vasoconstriction in humans: Evidence for mechanistic role of endogenous purine compounds. Circulation 82: 2061‐2067, 1990.
 389.Tainio H. Cytochemical localization of VIP‐stimulated adenylate cyclase activity in human sweat glands. Br J Dermatol 116: 323‐328, 1987.
 390.Takamata A, Nagashima K, Nose H, Morimoto T. Role of plasma osmolality in the delayed onset of thermal cutaneous vasodilation during exercise in humans. Am J Physiol 275: R286‐R290, 1998.
 391.Tam HS, Darling RC, Cheh HY, Downey JA. The dead zone of thermoregulation in normal and paraplegic man. Can J Physiol Pharmacol 56: 976‐983, 1978.
 392.Tartas M, Bouyé P, Koïtka A, Jaquinandi V, Tan L, Saumet JL, Abraham P. Cathodal current‐induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin‐sensitive mechanisms. J Appl Physiol 99: 1538‐1544, 2005.
 393.Taylor WF, Bishop VS. A role for nitric oxide in active thermoregulatory vasodilation. Am J Physiol 264: H1355‐H1359, 1993.
 394.Taylor WF, DiCarlo SE, Bishop VS. Neurogenic vasodilator control of rabbit ear blood flow. Am J Physiol Regulatory Integrative Comp Physiol 262: R766‐R770, 1992.
 395.Taylor WF, Johnson JM, Kosiba WA. Roles of absolute and relative load in skin vasoconstrictor responses to exercise. J Appl Physiol 69: 1131‐1136, 1990.
 396.Taylor WF, Johnson JM, Kosiba WA, Kwan CM. Graded cutaneous vascular responses to dynamic leg exercise. J Appl Physiol 64: 1803‐1809, 1988.
 397.Taylor WF, Johnson JM, Kosiba WA, Kwan CM. Cutaneous vascular responses to isometric handgrip exercise. J Appl Physiol 66: 1586‐1592, 1989.
 398.Taylor WF, Johnson JM, O'Leary D, Park MK. Effect of high local temperature on reflex cutaneous vasodilation. J Appl Physiol 57: 191‐196, 1984a.
 399.Taylor WF, Johnson JM, O'Leary D, Park MK. Modification of the cutaneous vascular response to exercise by local skin temperature. J Appl Physiol 57: 1878‐1884, 1984b.
 400.Tew GA, Klonizakis M, Crank H, Briers JD, Hodges GJ. Comparison of laser speckle contrast imaging with laser Doppler for assessing microvascular function. Microvasc Res 82: 326‐332, 2011.
 401.Tew GA, Klonizakis M, Moss J, Ruddock AD, Saxton JM, Hodges GJ. Role of sensory nerves in the rapid cutaneous vasodilator response to local heating in young and older endurance‐trained and untrained men. Exp Physiol 96: 163‐170, 2011.
 402.Tew GA, Saxton JM, Klonizakis M, Moss J, Ruddock AD, Hodges GJ. Aging and aerobic fitness affect the contribution of noradrenergic sympathetic nerves to the rapid cutaneous vasodilator response to local heating. J Appl Physiol 110: 1264‐1270, 2011.
 403.Thauer R. Circulatory adjustments to climatic requirements. In: Handbook of Physiology, section 2, Circulation, vol III, ed. Hamilton WF & Dow P. chapter 55, pp. 1921‐1966. American Physiological Society, Washington, DC, 1965.
 404.Thompson CS, Holowatz LA, Kenney WL. Attenuated noradrenergic sensitivity during local cooling in aged human skin. J Physiol 564: 313‐319, 2005.
 405.Thompson CS, Kenney WL. Altered neurotransmitter control of reflex vasoconstriction in aged human skin. J Physiol 558: 697‐704, 2004.
 406.Thompson‐Torgerson CS, Holowatz LA, Flavahan NA, Kenney WL. Cold‐induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am J Physiol Heart Circ Physiol 292: H1700‐H1705, 2007.
 407.Thompson‐Torgerson CS, Holowatz LA, Flavahan NA, Kenney WL. Rho kinase‐mediated local cold‐induced cutaneous vasoconstriction is augmented in aged human skin. Am J Physiol Heart Circ Physiol 293: H30‐H36, 2007.
 408.Thompson‐Torgerson CS, Holowatz LA, Kenney WL. Altered mechanisms of thermoregulatory vasoconstriction in aged human skin. Exercise Sports Sci Rev 36: 122‐127, 2008.
 409.Thoresen M, Walløe L. Skin blood flow in humans as a function of environmental temperature measured by ultrasound. Acta Physiol Scand 109: 333‐341, 1980.
 410.Toda N, Imamura T, Okamura T. Alteration of nitric oxide‐mediated blood flow regulation in diabetes mellitus. Pharmacol Ther 127: 189‐209, 2010.
 411.Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain‐producing stimuli. Neuron 21: 531‐543, 1998.
 412.Tooke JE. Microvasculature in diabetes. Cardiovasc Res 32: 764‐771, 1996.
 413.Tripathi A, Nadel ER. Forearm skin and muscle vasoconstrictin during lower body negative pressure. J Appl Physiol 60: 1535‐1541, 1986.
 414.Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 18: 109‐116, 2008.
 415.Vaalasti A, Tainio H, Rechardt L. Vasoactive intestinal polypeptide (VIP)‐like immunoreactivity in the nerves of human axillary sweat glands. J Investigative Dermatol 85: 246‐248, 1985.
 416.Vanhoutte PM, Shepherd JT. Effect of temperature on reactivity of isolated cutaneous veins of the dog. Am J Physiol 218: 187‐190, 1970.
 417.Vanhoutte PM, Shepherd JT. Adrenergic pharmacology of human and canine peripheral veins. Fed Proc 44: 337‐340, 1985.
 418.Venturini G, Colasanti M, Fioravanti E, Bianchini A, Pascenzi P. Direct effect of temperature on the catalytic activity of nitric oxide synthases types I, II and III. Nitric Oxide 3: 375‐382, 1999.
 419.Vials A, Burnstock G. A2‐purinoceptor‐mediated relaxation in the guinea‐pig coronary vasculature: A role for nitric oxide. Br J Pharmacol 109: 424‐429, 1993.
 420.Vinik AI, Erbas T, Park TS, Stansberry KB, Scanelli JA, Pittenger GL. Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care 24: 1468‐1475, 2001.
 421.Vinik AI, Ullal J, Parson HK, Barlow PM, Casellini CM. Pioglitazone treatment improves nitrosative stress in type 2 diabetes. Diabetes Care 29: 869‐876, 2006.
 422.Vissing SF, Hjortsø EM. Central motor command activates sympathetic outflow to the cutaneous circulation in humans. J Physiol 492(Pt 3): 931‐939, 1996.
 423.Vissing SF, Scherrer U, Victor RG. Increase of sympathetic discharge to skeletal muscle but not to skin during mild lower body negative pressure in humans. J Physiol 481(Pt 1): 233‐241, 1994.
 424.Vissing SF, Secher NH, Victor RG. Mechanisms of cutaneous vasoconstriction during upright posture. Acta Physiol Scand 159: 131‐138, 1997.
 425.Wahlestedt C, Hakanson R, Vaz CA, Zukowska‐Grojec Z. Norepinephrine and neuropeptide Y: Vasoconstrictor cooperation in vivo and in vitro. Am JPhysiol 258: R736‐R742, 1990.
 426.Wallengren J. Vasoactive peptides in the skin. J Investigative Derm Symp Proceedings 2: 49‐55, 1997.
 427.Wallengren J, Håkanson R. Effects of substance P, neurokinin A and calcitonin gene‐related peptide in human skin and their involvement in sensory nerve‐mediated responses. Eur J Pharmacol 143: 267‐273, 1987.
 428.Wallin BG, Sundlöf G, Delius W. The effect of carotid sinus nerve stimulation on muscle and skin nerve sympathetic activity in man. Pflugers Arch 358: 101‐110, 1975.
 429.Warren JB, Cockcroft JR, Larkin SW, Kajekar R, Macrae A, Ghatei MA, Bloom SR. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans. J Cardiovascular Pharmacology 20: 83‐87, 1992.
 430.Warren JB, Loi RK. Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins. FASEB J 9: 411‐418, 1995.
 431.Wenger CB, Roberts MF, Stolwijk JAJ, Nadel ER. Forearm blood flow during body temperature transients produced by leg exercise. J Appl Physiol 38: 58‐63, 1975.
 432.Wenner MM, Taylor HS, Stachenfeld NS. Progesterone enhances adrenergic control of skin blood flow in women with high but not low orthostatic tolerance. J Physiol 589: 975‐986, 2011.
 433.Wenzel RR, Rüthemann J, Bruck H, Schäfers RF, Michel MC, Philipp T. Endothelin‐A receptor antagonist inhibits angiotensin II and noradrenaline in man. Br J Clin Pharmacol 52: 151‐157, 2001.
 434.Whitney RJ. The measurement of volume changes in human limbs. J Physiol (London) 121: 1‐27, 1953.
 435.Wick DE, Roberts SK, Basu A, Sandroni P, Fealey RD, Sletten D, Charkoudian N. Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus. J Appl Physiol 100: 637‐641, 2006.
 436.Wigington G, Ngo B, Rendell M. Skin blood flow in diabetic dermopathy. Arch Dermatol 140: 1248‐1250, 2004.
 437.Wilkins BW, Chung LH, Tublitz NJ, Wong BJ, Minson CT. Mechanisms of vasoactive intestinal peptide‐mediated vasodilation in human skin. J Appl Physiol 97: 1291‐1298, 2004.
 438.Wilkins BW, Holowatz LA, Wong BJ, Minson CT. Nitric oxide is not permissive for cutaneous active vasodilation in humans. J Physiol 548: 963‐969, 2003.
 439.Wilkins BW, Martin EA, Roberts SK, Joyner MJ. Preserved reflex vasodilation in cystic fibrosis does not include an enhanced nitric oxide‐dependent mechanism. J Appl Physiol 102: 2301‐2306, 2007.
 440.Wilkins BW, Wong BJ, Tublitz NJ, McCord GR, Minson CT. The vasoactive intestinal peptide fragment VIP10‐28 and active vasodilation in human skin. J Appl Physiol 99: 2284‐2301, 2005.
 441.Williamson JW, Fadel PJ, Mitchell JH. New insights into central cardiovascular control during exercise in humans: A central command update. Exp Physiol 91: 51‐58, 2006.
 442.Wilson TE, Cui J, Crandall CG. Effect of whole‐body and local heating on cutaneous vasoconstrictor responses in humans. Autonom Neurosci: Basic Clin 97: 122‐128, 2002.
 443.Wingo JE, Low DA, Keller DM, Brothers RM, Shibasaki M, Crandall CG. Effect of elevated local temperature on cutaneous vasoconstrictor responsiveness in humans. J Appl Physiol 106: 571‐575, 2009.
 444.Witte K, Hachenberger J, Castell MF, Vahl CF, Haller C. Nitric oxide‐sensitive soluble guanylyl cyclase activity is preserved in internal mammary artery of type 2 diabetic patients. Diabetes 53: 2640‐2644, 2004.
 445.Wong BJ, Fieger SM. Transient receptor potential vanilloid type‐1 (TRPV‐1) channels contribute to cutaneous thermal hyperaemia in humans. J Physiol 588: 4317‐4326, 2010.
 446.Wong BJ, Fieger SM. Transient receptor potential vanilloid type 1 channels contribute to reflex cutaneous vasodilation in humans. J Appl Physiol 112: 2037‐2042, 2012.
 447.Wong BJ, Minson CT. Neurokinin‐1 receptor desensitization attenuates cutaneous active vasodilation in humans. J Physiol 577: 1043‐1051, 2006.
 448.Wong BJ, Minson CT. Altered thermal hyperaemia in human skin by prior desensitization of neurokinin‐1 receptors. Exp Physiol 96: 599‐609, 2011.
 449.Wong BJ, Tublitz NJ, Minson CT. Neurokinin‐1 receptor desensitization to consecutive microdialysis infusions of substance P in humans. J Physiol 568: 1047‐1056, 2005.
 450.Wong BJ, Wilkins BW, Holowatz LA, Minson CT. Nitric oxide synthase inhibition does not alter the reactive hyperemic response in the cutaneous circulation. J Appl Physiol 95: 504‐510, 2003.
 451.Wong BJ, Wilkins BW, Minson CT. H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans. J Physiol 560: 941‐948, 2004.
 452.Wong BJ, Williams SJ, Minson CT. Minimal role for H1 and H2 histamine receptors in cutaneous thermal hyperemia to local heating in humans. J Appl Physiol 100: 535‐540, 2006.
 453.Wyss CR, Brengelmann GL, Johnson JM, Rowell LB, Niederberger M. Control of skin blood flow, sweating and heart rate: Role of skin vs. core temperature. J Appl Physiol 36: 726‐733, 1974.
 454.Yamashita Y, Ogawa T, Ohnishi N, Imamura R, Sugenoya J. Local effect of vasoactive intestinal polypeptide on human sweat‐gland function. Jpn J Physiol 37: 929‐936, 1987.
 455.Yamazaki F. Local ascorbate administration inhibits the adrenergic vasoconstrictor response to local cooling in the human skin. J Appl Physiol 108: 328‐333, 2010.
 456.Yamazaki F. Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin. J Appl Physiol 112: 1689‐1697, 2012.
 457.Yamazaki F, Sone R, Zhao K, Alvarez GE, Kosiba WA, Johnson JM. Rate dependency and role of nitric oxide in the vascular response to direct cooling in human skin. J Appl Physiol 100: 42‐50, 2006.
 458.Young AJ. Homeostatic Responses to Prolonged Cold Exposure: Human Cold Acclimatization. Wiley Online Library, 1994.
 459.Zelis R, Mason DT, Braunwald E. Partition of blood flow to the cutaneous and muscular beds of the forearm at rest and during leg exercise in normal subjects and in patients with heart failure. Circ Res 24: 799‐806, 1969.
 460.Zhao JL, Pergola PE, Roman LJ, Kellogg DL, Jr. Bioactive nitric oxide concentration does not increase during reactive hyperemia in humans. J Appl Physiol 96: 628‐632, 2004.
 461.Zimmerman BG. Influence of sympathetic stimulation on segmental vascular resistance before and after adrenergic neuronal blockade. Arch Int Pharmacodyn Ther 160: 66‐82, 1966.
 462.Zoller RP, Mark AL, Abboud FM, Schmid PG, Heistad DD. The role of low pressure baroreceptors in reflex vasoconstrictor responses in man. J Clin Invest 51: 2967‐2972, 1972.

Contact Editor

Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Cutaneous Vasodilator and Vasoconstrictor Mechanisms in Temperature Regulation
 

How to Cite

John M. Johnson, Christopher T. Minson, Dean L. Kellogg. Cutaneous Vasodilator and Vasoconstrictor Mechanisms in Temperature Regulation. Compr Physiol 2014, 4: 33-89. doi: 10.1002/cphy.c130015